{
    "testId": 374295911,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 15,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 26,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 1,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 2579,
    "averageTimeSpentInSeconds": 116,
    "otherAverageTimeSpentInSeconds": 60,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 19014,
            "questionIndex": 20497,
            "questionText": "<p>A 56-year-old woman comes to the office for a follow-up.&nbsp; Six months ago, the patient was diagnosed with major depressive disorder during an evaluation for low energy, poor sleep, weight gain, and difficulty concentrating at work.&nbsp; She was initially treated with escitalopram, but her depressive symptoms were only slightly improved after 2 months of treatment.&nbsp; Her medication was switched to venlafaxine, which was subsequently titrated to maximal therapeutic dosage over the course of 3 months.&nbsp; The patient reports that her depression has improved with treatment, although she still has occasional insomnia.&nbsp; Her energy has increased back to baseline level; she now feels motivated to exercise and has lost 5 pounds.&nbsp; The patient has no other medical conditions and takes no other medications.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Which of the following should be monitored at this visit?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Serotonin-norepinephrine reuptake inhibitors</strong> (SNRIs) (eg, venlafaxine, duloxetine) are frequently prescribed as next step treatment after an adequate trial of a selective serotonin reuptake inhibitor (SSRI) (eg, escitalopram) fails.&nbsp; Many SNRIs, including venlafaxine, are associated with <strong>dose-dependent increases in diastolic and systolic blood pressure</strong>.&nbsp; Blood pressure should be assessed before starting an SNRI and regularly monitored throughout treatment.</p><p>As a class, SNRIs inhibit the reuptake of both serotonin and norepinephrine.&nbsp; <strong>Venlafaxine</strong> has the unique property of possessing significantly higher affinity for the serotonin transporter relative to the norepinephrine transporter, which results in venlafaxine behaving like an SSRI at lower doses and demonstrating significant norepinephrine reuptake inhibition at higher doses.&nbsp; Because this <strong>noradrenergic drive</strong> is what leads to hypertension, the risk with venlafaxine is most pronounced at doses &#8805;225 mg.&nbsp; If sustained increases in blood pressure are noted, options include dose reduction or switching to an alternate antidepressant.</p><p><strong>(Choice A)</strong>&nbsp; Plasma levels of SNRIs are not routinely monitored and would not be indicated in a patient experiencing a positive response.&nbsp; Levels can be used to assess adherence or to identify rapid metabolizers in poor responders.</p><p><strong>(Choice C)</strong>&nbsp; Complete blood counts are not routinely monitored during venlafaxine treatment.&nbsp; SNRIs have been associated with a small increased risk of bleeding due to impaired platelet aggregation, but this is mainly a concern in patients who are already taking anticoagulants.&nbsp; Monitoring for agranulocytosis is required in patients taking clozapine (eg, for schizophrenia).</p><p><strong>(Choice D)</strong>&nbsp; Regular monitoring of lipids is not required in patients taking venlafaxine.&nbsp; Lipids should be routinely monitored in those taking antipsychotics.</p><p><strong>(Choice E)</strong>&nbsp; Venlafaxine is not associated with adverse thyroid effects, and monitoring thyroid function tests during treatment is unnecessary.&nbsp; This patient&#39;s initial weight gain was most likely a symptom of her depression (ie, atypical depression frequently presents with increased appetite), and her subsequent weight loss is most likely due to her improvement.</p><p><strong>Educational objective:</strong><br>The serotonin-norepinephrine reuptake inhibitor venlafaxine is associated with dose-dependent hypertension due to increased norepinephrine reuptake inhibition at higher dose ranges.&nbsp; Blood pressure should be assessed before starting venlafaxine and regularly monitored throughout treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antidepressant plasma level",
                    "choiceNumber": 1,
                    "correctTaken": 762,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Blood pressure",
                    "choiceNumber": 2,
                    "correctTaken": 12902,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Complete blood count",
                    "choiceNumber": 3,
                    "correctTaken": 677,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lipid panel",
                    "choiceNumber": 4,
                    "correctTaken": 1214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid function tests",
                    "choiceNumber": 5,
                    "correctTaken": 1485,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "569,870,true,-1,1*984,998,true,-1,1*1451,1638,true,-1,1*2122,2186,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30838456",
                    "mediaDataId": 0,
                    "title": "Serotonin and norepinephrine reuptake inhibitors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30838456",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25328745",
                    "mediaDataId": 0,
                    "title": "Accelerated hypertension after venlafaxine usage.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25328745",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 77,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 17040,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 445,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 14539,
            "questionIndex": 15949,
            "questionText": "<p>A 26-year-old woman, gravida 1 para 1, comes to the office for a 6-week postpartum checkup following an induction of labor and vaginal delivery at 38 weeks gestation for preeclampsia with severe features.&nbsp; Her pregnancy was otherwise uncomplicated, and the patient has no chronic medical conditions.&nbsp; She is currently breastfeeding and supplementing with pumped breast milk.&nbsp; The patient has not resumed her menses and is taking a progestin-only pill for contraception.&nbsp; The patient says, &#x22;The baby is healthy, which is great, but I haven&#39;t been sleeping much and have been very tired.&nbsp; My mom is coming to stay with us, so I&#39;m hoping to get some rest soon.&#x22;&nbsp; Temperature is 36.7 C (98 F), blood pressure is 130/80 mm Hg, and pulse is 68/min.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Breast and pelvic examinations are normal.&nbsp; Which of the following should be performed at this visit?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t43825\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>Postpartum blues, depression &amp; psychosis</strong></p></td></tr><tr><td style=\"width: 16%;\"></td><td style=\"width: 26%;\"><p align=\"center\"><strong>Postpartum blues</strong></p></td><td style=\"width: 30%;\"><p align=\"center\"><strong>Postpartum depression</strong></p></td><td style=\"width: 28%;\"><p align=\"center\"><strong>Postpartum psychosis</strong></p></td></tr><tr><td style=\"width: 16%;\"><p align=\"center\"><strong>Prevalence</strong></p></td><td style=\"width: 26%;\"><ul><li>40%-80%</li></ul></td><td><ul><li>8%-15%</li></ul></td><td style=\"width: 28%;\"><ul><li>0.1%-0.2%</li></ul></td></tr><tr><td style=\"width: 16%;\"><p align=\"center\"><strong>Onset</strong></p></td><td style=\"width: 26%;\"><ul><li>2-3 days (resolves within 14 days)</li></ul></td><td style=\"width: 30%;\"><ul><li>Typically within 4-6 weeks (can be up to 1 year)</li></ul></td><td style=\"width: 28%;\"><ul><li>Days to weeks</li></ul></td></tr><tr><td style=\"width: 16%;\"><p align=\"center\"><strong>Symptoms</strong></p></td><td style=\"width: 26%;\"><ul><li>Mild depression, tearfulness, irritability</li></ul></td><td style=\"width: 30%;\"><ul><li>&ge;2 weeks of moderate to severe depression, sleep&nbsp;or appetite disturbance, low energy, psychomotor changes, guilt, concentration difficulty, suicidal ideation</li></ul></td><td style=\"width: 28%;\"><ul><li>Delusions, hallucinations, thought disorganization, bizarre behavior</li></ul></td></tr></tbody></table></div><p><strong>Postpartum depression</strong> (also known as depression with postpartum onset) is common, affecting up to 15% of mothers, and typically develops within 4-6 weeks after delivery.&nbsp; It poses a significant risk to both maternal and infant well-being because women with postpartum depression can have difficulty with infant bonding and breastfeeding and are at risk for suicide and infanticide.</p><p>Patients sometimes do not recognize the symptoms of postpartum depression because they often overlap with a normal postpartum course, as evidenced by the fatigue and sleep disturbance experienced by this patient.&nbsp; In addition, women may <strong>underreport symptoms</strong> due to fear of stigmatization and preconceived maternal roles (eg, immediate bonding).</p><p>Because of the <strong>high incidence</strong> of postpartum depression and underreporting of symptoms, <strong>all women require screening</strong> (regardless of prior psychiatric history) with a standardized, validated tool such as the <strong>Edinburgh Postnatal Depression Scale</strong> (EPDS).&nbsp; The EPDS has a high sensitivity (90%); women with a positive screen for postpartum depression require further evaluation, treatment, and close follow-up.</p><p><strong>(Choice A)</strong>&nbsp; A 24-hour urine protein collection is used to diagnose preeclampsia.&nbsp; Although this patient had preeclampsia with severe features during her pregnancy, most cases of preeclampsia resolve after delivery&mdash;as is likely in this patient with a normal postpartum blood pressure.</p><p><strong>(Choice C)</strong>&nbsp; Postpartum glucose tolerance testing is performed in patients who had gestational diabetes mellitus to evaluate for overt type 2 diabetes mellitus postpartum.</p><p><strong>(Choice D)</strong>&nbsp; If this patient&#39;s depression screening is positive, she may require evaluation for medical causes of depression, such as hypothyroidism (eg, thyroid function tests).</p><p><strong>(Choice E)</strong>&nbsp; A transvaginal ultrasound can be performed postpartum if there is concern for retained placenta (eg, persistent vaginal bleeding, malodorous lochia) or a new pregnancy.&nbsp; Not resuming menses at 6 weeks postpartum is common in breastfeeding women; pregnancy is unlikely in this patient who has lactational amenorrhea and is also using contraception.</p><p><strong>Educational objective:</strong><br>Postpartum depression has a high incidence and is often underreported.&nbsp; Therefore, all women (regardless of prior psychiatric history) require screening for postpartum depression (eg, Edinburgh Postnatal Depression Scale).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 14953,
            "topic": "Peripartum depression",
            "titleId": 14953,
            "title": "Peripartum depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "24-hour urine protein collection",
                    "choiceNumber": 1,
                    "correctTaken": 1521,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Edinburgh postnatal depression scale",
                    "choiceNumber": 2,
                    "correctTaken": 13336,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucose tolerance test",
                    "choiceNumber": 3,
                    "correctTaken": 366,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid function tests",
                    "choiceNumber": 4,
                    "correctTaken": 1338,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transvaginal ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 55,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2148,2315,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25932866",
                    "mediaDataId": 0,
                    "title": "The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25932866",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26813212",
                    "mediaDataId": 0,
                    "title": "Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26813212",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24943697",
                    "mediaDataId": 0,
                    "title": "Concise review for physicians and other clinicians: postpartum depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24943697",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30599376",
                    "mediaDataId": 0,
                    "title": "Validation of the Edinburgh postnatal depression scale as a screening tool for depression in Spanish pregnant women.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30599376",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 138,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 16616,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 486,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 17597,
            "questionIndex": 19056,
            "questionText": "<p>A 17-year-old girl comes to the office for a routine maintenance evaluation.&nbsp; The patient is thinking about having sex for the first time.&nbsp; She has been in a relationship for 6 months and would like to have a &#x22;physical connection&#x22; with her boyfriend.&nbsp; The patient has not felt pressured by him and feels comfortable and safe in the relationship.&nbsp; She has fantasies often about having sex with her boyfriend and masturbates 4 or 5 times a week.&nbsp; The patient has no history of partnered sexual activity.&nbsp; Which of the following is the most appropriate response by the physician at this time?</p>",
            "questionHeader": "",
            "explanationText": "<p>Medical aspects of sexual health (eg, contraceptive options, STI prevention) should be addressed at all routine health care visits for adolescents.&nbsp; However, physicians may also be adolescents&#39; only trusted source of information about sexuality and are in a unique position to help adolescents feel comfortable asking any questions they may have.&nbsp; Keys to promoting open discussion include providing a <strong>private</strong> setting, <strong>assuring confidentiality</strong>, <strong>normalizing discussions</strong> of sex, removing stigma and discomfort by being <strong>nonjudgmental</strong>, and avoiding assumptions by using <strong>open-ended</strong> and <strong>gender-neutral</strong> questions about identity and sexual behaviors.</p><p>This patient has been forthcoming about her thoughts of becoming sexually active with her boyfriend.&nbsp; The best response is to convey that it is normal to have questions and begin an open-ended discussion of any concerns that she may have.&nbsp; This should precede the physician&#39;s redirection of the conversation to specific counseling regarding contraceptive options and STI prevention, which may inadvertently discourage the patient from bringing up her own questions and concerns <strong>(Choices A and C)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Confidentiality should be emphasized when discussing sexual issues, especially with adolescents.&nbsp; It is premature to encourage this patient to share her plans with her parents without first exploring her concerns or understanding her relationship with her parents.</p><p><strong>(Choice D)</strong>&nbsp; This response could make the patient feel defensive about her plans to have sex, which may preclude an open discussion about healthy and safe sexual practices.</p><p><strong>Educational objective:</strong><br>Physicians are in a unique position to answer adolescents&#39; questions about sexuality.&nbsp; Keys to promoting open discussion include providing a private setting, assuring confidentiality, normalizing discussions of sex, removing stigma and discomfort by being nonjudgmental, and avoiding assumptions by using open-ended and gender-neutral questions.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 11037,
            "topic": "Child and adolescent mental health",
            "titleId": 11037,
            "title": "Child and adolescent mental health",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Deciding when to have sex is up to you, but we should talk about ways to protect yourself from sexually transmitted infections.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 3364,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Having sex for the first time is a big decision; have you thought about discussing it with your parents?&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 121,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;It sounds like you may decide to have sex with your boyfriend soon; have you thought about how to prevent an unintended pregnancy?&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 1627,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;It&#39;s normal for teenagers to experiment with sexual activities; but do you think you&#39;re ready to have sex?&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 81,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Wondering about when to have sex is very normal; what questions do you have about sex and your body?&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 14624,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28391967",
                    "mediaDataId": 0,
                    "title": "Physicians talking about sex, sexuality, and protection with adolescents.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28391967",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 74,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 19817,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 371,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 2510,
            "questionIndex": 2510,
            "questionText": "<p>A 27-year-old man is brought to the office by his wife due to her concerns that &#x22;he is not himself.&#x22;&nbsp; The patient has been very irritable and hyperactive with difficulty sleeping since returning from a family funeral a week ago.&nbsp; His wife reports that he has been very distracted and unproductive at the factory where he works, to the point that his employer has placed him on probation.&nbsp; Two days ago, he nearly sustained a serious injury while performing risky maneuvers with heavy machinery.&nbsp; When asked about his job, the patient says he has had no difficulties and describes his idea to &#x22;use special robot prosthetics to make the production line faster than ever and double everyone&#39;s productivity.&#x22;&nbsp; The patient adds, &#x22;I don&#39;t know what my wife is worried about.&nbsp; If this job doesn&#39;t work out, I&#39;ll start my own company.&#x22;&nbsp; His wife reports that he behaved similarly about 2 years ago and embarrassed her at a party by talking incessantly about his idea for a robotic invention.&nbsp; The patient has no history of depression.&nbsp; He drinks 2 or 3 beers on weekends and has been smoking marijuana approximately once a month for the past year.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 110/80 mm Hg, and pulse is 86/min.&nbsp; Urine toxicology screen is positive for tetrahydrocannabinol.&nbsp; Except for marked restlessness and fidgeting, physical examination is unremarkable.&nbsp; Which of the following is the most likely explanation for the patient&#39;s behavior?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s 1-week history of irritable mood, hyperactivity, distractibility, impulsivity, decreased sleep, and grandiosity resulting in severe impairment (risky behavior at work resulting in probation and a near serious injury) suggest a <strong>manic episode</strong>.&nbsp; The presence of a manic episode&nbsp;makes&nbsp;<strong>bipolar I disorder</strong> the most likely diagnosis.</p><p>The diagnosis of hypomanic and manic episodes requires <strong>elevated/irritable mood</strong> and <strong>increased energy</strong>, plus 3 of the following (or 4 if mood is irritable):</p><ul><li><strong>D</strong> - Distractibility</li><li><strong>I</strong> - Impulsivity (high-risk behaviors [eg, spending, sexual])</li><li><strong>G</strong> - Grandiosity</li><li><strong>F</strong> - Flight of ideas/racing thoughts</li><li><strong>A</strong> - Activity (increased goal-directed activity/psychomotor agitation)</li><li><strong>S</strong> - Sleep (decreased need)</li><li><strong>T</strong> - Talkativeness/pressured speech</li></ul><p>In hypomania, symptoms are less severe and functioning is improved or only slightly impaired, unlike in this patient who is on probation and whose risky behavior could have resulted in serious injury.&nbsp; If psychotic symptoms are present, the episode is manic by definition.&nbsp; Diagnosis of bipolar I disorder does not require a history of major depressive episodes.&nbsp; Bipolar II disorder is characterized by episodes of major depression and hypomania (not mania, as in this patient) <strong>(Choice C)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Some symptoms of mania overlap with those of attention-deficit hyperactivity disorder (ADHD) (eg, hyperactivity, distractibility, impulsivity).&nbsp; However, ADHD symptoms are chronic, not episodic.</p><p><strong>(Choice D)</strong>&nbsp; Cyclothymic disorder involves 2 years of fluctuating periods with mild depressive symptoms as well as symptoms of hypomania that never meet the full criteria for hypomanic, manic, or major depressive episodes.</p><p><strong>(Choice E)</strong>&nbsp; The diagnosis of schizoaffective disorder requires a depressive or manic episode co-occurring with symptoms of schizophrenia and a lifetime history of &#8805;2 weeks of psychotic symptoms in the absence of mood episodes.</p><p><strong>(Choice F)</strong>&nbsp; Although this patient&#39;s urine toxicology screen is positive for tetrahydrocannabinol (eg, marijuana), he has a history suggestive of a mood episode prior to his use of marijuana, which started within the past year.&nbsp; In addition, although cannabis intoxication can present with&nbsp;euphoria,&nbsp;anxiety, or psychosis, it is more likely to cause psychomotor slowing rather than hyperactivity.&nbsp; Intoxication with stimulants or cocaine is more likely to induce manic symptoms.</p><p><strong>Educational objective:</strong><br>Bipolar I disorder includes manic episode(s) with or without a history of major depressive episodes.&nbsp; Bipolar II is distinguished from bipolar I by hypomanic episodes (less severe, less functional impairment, no psychotic symptoms) and a history of &#8805;1 depressive episodes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adult attention-deficit hyperactivity disorder",
                    "choiceNumber": 1,
                    "correctTaken": 220,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar I disorder",
                    "choiceNumber": 2,
                    "correctTaken": 10548,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar II disorder",
                    "choiceNumber": 3,
                    "correctTaken": 2426,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cyclothymic disorder",
                    "choiceNumber": 4,
                    "correctTaken": 972,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizoaffective disorder, bipolar type",
                    "choiceNumber": 5,
                    "correctTaken": 500,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Substance-induced mood disorder",
                    "choiceNumber": 6,
                    "correctTaken": 2282,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "372,790,true,-1,1*1853,1937,true,-1,1*2165,2415,true,-1,1*2573,2670,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "102",
                    "mediaDataId": 0,
                    "title": "Bipolar I disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23663952",
                    "mediaDataId": 0,
                    "title": "Bipolar disorder diagnosis: challenges and future directions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23663952",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24446541",
                    "mediaDataId": 0,
                    "title": "Differentiating bipolar I and II disorders and the likely contribution of DSM-5 classification to their cleavage.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24446541",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25406047",
                    "mediaDataId": 0,
                    "title": "Adult ADHD vs. bipolar disorder in the DSM-5 era: a challenging differentiation for clinicians.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25406047",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 152,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 16948,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 805,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 8897,
            "questionIndex": 8913,
            "questionText": "<p>A 61-year-old woman comes to the office accompanied by her daughter due to headaches.&nbsp; The headaches occur 2 or 3 times a week and feel like &#x22;a band around my head that someone is constantly tightening.&#x22;&nbsp; The patient also reports excessive tiredness, restless sleep, and decreased appetite, attributing these symptoms to aging.&nbsp; She has no visual disturbances, dizziness, vomiting, weakness, or other neurologic symptoms.&nbsp; The patient experienced similar headaches a few years ago; after they restarted 2 months ago, she was persuaded by her daughter to get evaluated.&nbsp; The daughter mentions that her mother moved in with her a few months ago due to recent unemployment and financial concerns.&nbsp; Since moving, the patient has not been going out with friends and says, &#x22;I get anxious driving from my daughter&#39;s house because I don&#39;t know the roads.&#x22;&nbsp; She was diagnosed with type 2 diabetes mellitus 2 years ago; hemoglobin A1c was 5.8% 2 months ago.&nbsp; Medications include metformin and ibuprofen as needed.&nbsp; Medical history is otherwise noncontributory.&nbsp; Vital signs are within normal limits, and physical examination is unremarkable.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s classic description of tension-type headaches, normal examination, and other symptoms suggestive of depression (eg, poor sleep, loss of appetite, fatigue, anxiety), may indicate an underlying psychiatric disorder.&nbsp; Patients with depression or anxiety often come to the office with <strong>headaches</strong> or other <strong>physical symptoms</strong> (eg, fatigue, <strong>insomnia</strong>, <strong>nonspecific aches and pains</strong>) due to a lack of psychologic awareness or a perceived stigma around mental health issues.</p><p>In the absence of new physical findings in a medically stable patient, the most appropriate next step is to screen the patient for depression by specifically <strong>inquiring</strong> about <strong>depressive symptoms</strong> (eg, depressed mood, anhedonia).&nbsp; For patients who may be unaware of or reluctant to admit to feeling depressed, asking if they are able to enjoy their usual activities is helpful.</p><p><strong>(Choice A)</strong>&nbsp; Obtaining further collateral information from the daughter may be useful but should not take precedence over obtaining a thorough history from the patient.</p><p><strong>(Choice C)</strong>&nbsp; Neuroimaging would not be helpful because this patient describes typical tension-type headaches similar to those she had a few years ago.&nbsp; In addition, her neurologic examination is normal.</p><p><strong>(Choice D)</strong>&nbsp; This patient has stable glycemic control as demonstrated by the normal hemoglobin A1c level taken 2 months ago; a repeat hemoglobin A1c level is not indicated at this time.</p><p><strong>(Choice E)</strong>&nbsp; Although reassurance regarding the benign nature of the headaches and regular follow-up is indicated, assessment for depression is a priority given the other symptoms suggestive of this condition.</p><p><strong>(Choice F)</strong>&nbsp; Although relaxation techniques and biofeedback can be considered in the management of tension-type headaches, it would be premature to recommend this intervention prior to evaluating for depression.</p><p><strong>(Choice G)</strong>&nbsp; Although giant cell arteritis (evaluated by temporal artery biopsy) can cause headache and fatigue, it is typically characterized by new headaches, abrupt onset of visual disturbances, jaw claudication, and constitutional symptoms such as fever.&nbsp; This patient&#39;s headaches are suggestive of recurrent tension-type headaches.</p><p><strong>Educational objective:</strong><br>Patients with underlying mood disorders frequently come to the office with physical rather than psychologic symptoms.&nbsp; Evaluation should include screening for depression by inquiring about mood and ability to enjoy usual activities.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ask permission to speak with the daughter alone",
                    "choiceNumber": 1,
                    "correctTaken": 468,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inquire about the patient&#39;s ability to enjoy usual activities",
                    "choiceNumber": 2,
                    "correctTaken": 13503,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a CT scan of the brain",
                    "choiceNumber": 3,
                    "correctTaken": 832,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a hemoglobin A1c level",
                    "choiceNumber": 4,
                    "correctTaken": 169,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance and schedule regular follow-up",
                    "choiceNumber": 5,
                    "correctTaken": 345,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend relaxation techniques and biofeedback",
                    "choiceNumber": 6,
                    "correctTaken": 1598,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schedule a temporal artery biopsy",
                    "choiceNumber": 7,
                    "correctTaken": 125,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "259,416,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27270532",
                    "mediaDataId": 0,
                    "title": "Overlap between headache, depression, and anxiety in general neurological clinics: a cross-sectional study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27270532",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20843358",
                    "mediaDataId": 0,
                    "title": "Patients presenting with somatic complaints in general practice: depression, anxiety and somatoform disorders are frequent and associated with psychosocial stressors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20843358",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 155,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 17040,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 304,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 4043,
            "questionIndex": 4043,
            "questionText": "<p>A 28-year-old man with bipolar I disorder comes to the office for a follow-up visit.&nbsp; He experienced his first manic episode 7 years ago, and the disorder responded well to lithium.&nbsp; The patient became nonadherent with his medication after his condition improved and then experienced a second manic episode 9 months later.&nbsp; Over the next 5 years, he experienced 3 additional manic episodes, 2 depressive episodes, and a suicide attempt.&nbsp; Since his most recent hospitalization for a manic episode 3 years ago, he has remained on lithium and has had no depressive, manic, or hypomanic signs or symptoms.&nbsp; The patient also has no lithium adverse effects, and levels confirm that he is taking the medication as prescribed.&nbsp; Today, he inquires about the possibility of discontinuing lithium, adding that he does not want to be dependent on medication and is &#x22;in a much more stable place than before.&#x22;&nbsp; Which of the following is the most appropriate recommendation for this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"77605\" src=\"https://www.uworld.com/media/highresdefault/L106949.jpg\"  ></p><p><strong>Bipolar I disorder</strong> is a mood disorder characterized by &#8805;1 episodes of mania; it also often includes major depressive episodes.&nbsp; Patients with severe bipolar I disorder (eg, frequent relapses, suicide attempts, recurrent hospitalizations) <strong>require lifelong maintenance pharmacotherapy</strong> to reduce the risk for relapse.</p><p>Patients often struggle with the idea of taking medication for life and may want to discontinue maintenance pharmacotherapy for a variety of reasons (eg, adverse effects, desire to be &#x22;medication free,&#x22; poor illness awareness).&nbsp; However, in most bipolar patients, <strong>discontinuing maintenance treatment</strong> leads to a <strong>recurrent mood episode</strong> within a year.&nbsp; This patient&#39;s request to stop medication despite his history of 7 prior mood episodes, a suicide attempt, and a previous failed discontinuation attempt should cause alarm.&nbsp; In addition, lithium&#39;s protective effects against suicide would be lost.</p><p>In patients with limited insight into the dangers of stopping treatment, respect for patient autonomy must be balanced by the physician&#39;s responsibility to act in the best interest of the patient.&nbsp; <strong>Nonjudgmental education</strong> about realistic concerns for <strong>life-damaging consequences</strong> (eg, bankruptcy, incarceration, divorce), <strong>suicide</strong>, and future <strong>treatment resistance</strong> should be <strong>reinforced</strong>.&nbsp; With this patient, ongoing discussion over multiple sessions, rather than an immediate decision, is recommended.&nbsp; This allows further understanding of and working through this patient&#39;s fear of being &#x22;dependent&#x22; on medication and avoids an impulsive decision.</p><p><strong>(Choices B and D)</strong>&nbsp; Stopping medication altogether and/or pursuing psychotherapy alone places the patient at unnecessary risk for a recurrent mood episode.&nbsp; Although psychotherapy may be an important part of treatment, in patients with bipolar I disorder, it should be combined with medication management.</p><p><strong>(Choice C)</strong>&nbsp; This patient&#39;s bipolar I disorder is stable, and he is tolerating lithium without adverse effects; therefore, switching to an alternate treatment (eg, valproate, quetiapine) is not indicated.&nbsp; Furthermore, discontinuing lithium quickly poses a high risk for relapse and even suicide.&nbsp; The immediate focus should be on providing nonjudgmental education about the significant risks for medication nonadherence while encouraging a discussion over time.</p><p><strong>(Choice E)</strong>&nbsp; Given the relapse risk, an additional year of treatment followed by gradual discontinuation is contraindicated in this patient with severe bipolar I disorder.&nbsp; Indefinite maintenance therapy should be recommended.</p><p><strong>Educational objective:</strong><br>Bipolar I disorder is a highly recurrent illness requiring long-term maintenance pharmacotherapy to decrease the risk for relapse.&nbsp; Patients asking to stop maintenance treatment should be nonjudgmentally educated about the dangers of nonadherence.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Continue long-term lithium maintenance pharmacotherapy",
                    "choiceNumber": 1,
                    "correctTaken": 4698,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue lithium and recommend initiating psychotherapy",
                    "choiceNumber": 2,
                    "correctTaken": 25,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue lithium gradually over the course of 2-4 weeks and initiate valproate",
                    "choiceNumber": 3,
                    "correctTaken": 88,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue lithium gradually over the course of several months",
                    "choiceNumber": 4,
                    "correctTaken": 158,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend that the patient continue lithium for an additional year then discontinue gradually",
                    "choiceNumber": 5,
                    "correctTaken": 99,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1171,1325,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26979387",
                    "mediaDataId": 0,
                    "title": "Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26979387",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29536616",
                    "mediaDataId": 0,
                    "title": "Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29536616",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 94,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 5068,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 93,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 630,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 17273,
            "questionIndex": 18726,
            "questionText": "<p>A 26-year-old woman comes to the office due to insomnia.&nbsp; She had an uncomplicated vaginal delivery 3 weeks ago and is on maternity leave to care for her daughter.&nbsp; The patient awakens regularly at 4:00 AM although the infant is sleeping.&nbsp; During the day, she has little energy and forces herself to shower and care for the infant.&nbsp; The patient shares that her husband returned to work 2 weeks after the infant was born, and although she feels he tries to be supportive, she finds herself feeling annoyed with him at times.&nbsp; She is breastfeeding and supplementing with formula as needed.&nbsp; Vital signs are normal.&nbsp; Physical examination is unremarkable.&nbsp; The patient says, &#x22;I know it&#39;s pretty normal to feel this way with a newborn.&nbsp; I&#39;m sure I&#39;d feel better if I could just get some rest.&#x22;&nbsp; Which of the following is the most appropriate physician statement?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t43825\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>Postpartum blues, depression &amp; psychosis</strong></p></td></tr><tr><td style=\"width: 16%;\"></td><td style=\"width: 26%;\"><p align=\"center\"><strong>Postpartum blues</strong></p></td><td style=\"width: 30%;\"><p align=\"center\"><strong>Postpartum depression</strong></p></td><td style=\"width: 28%;\"><p align=\"center\"><strong>Postpartum psychosis</strong></p></td></tr><tr><td style=\"width: 16%;\"><p align=\"center\"><strong>Prevalence</strong></p></td><td style=\"width: 26%;\"><ul><li>40%-80%</li></ul></td><td><ul><li>8%-15%</li></ul></td><td style=\"width: 28%;\"><ul><li>0.1%-0.2%</li></ul></td></tr><tr><td style=\"width: 16%;\"><p align=\"center\"><strong>Onset</strong></p></td><td style=\"width: 26%;\"><ul><li>2-3 days (resolves within 14 days)</li></ul></td><td style=\"width: 30%;\"><ul><li>Typically within 4-6 weeks (can be up to 1 year)</li></ul></td><td style=\"width: 28%;\"><ul><li>Days to weeks</li></ul></td></tr><tr><td style=\"width: 16%;\"><p align=\"center\"><strong>Symptoms</strong></p></td><td style=\"width: 26%;\"><ul><li>Mild depression, tearfulness, irritability</li></ul></td><td style=\"width: 30%;\"><ul><li>&ge;2 weeks of moderate to severe depression, sleep&nbsp;or appetite disturbance, low energy, psychomotor changes, guilt, concentration difficulty, suicidal ideation</li></ul></td><td style=\"width: 28%;\"><ul><li>Delusions, hallucinations, thought disorganization, bizarre behavior</li></ul></td></tr></tbody></table></div><p>Although interrupted sleep is common in new mothers, several features of this patient&#39;s presentation are concerning for <strong>postpartum depression</strong> (ie, major depressive disorder with peripartum onset), including:</p><ul><li>marked <strong>sleep</strong> disturbance with early-morning awakening</li><li>low <strong>energy</strong></li><li><strong>amotivation</strong> (eg, forces herself to shower and care for the infant)</li></ul><p>leading to <strong>impaired functioning</strong>.</p><p>Postpartum depression is common and, if left untreated, can result in impaired maternal-infant bonding and negative impact on both maternal and infant health.&nbsp; Therefore, all women with <strong>mood symptoms after birth</strong> should be further <strong>screened for postpartum depression</strong>.&nbsp; In this situation, asking about <strong>hopelessness</strong> in a patient who struggles to identify depression (eg, &#x22;I know it&#39;s pretty normal,&#x22; &#x22;I&#39;d feel better if I could just get some rest&#x22;) provides the physician with another way of determining the presence of depressed mood (eg, <strong>sad</strong>, <strong>hopeless</strong>, <strong>empty</strong>).</p><p>If positive for postpartum depression, then appropriate treatment should include pharmacologic and therapeutic interventions <strong>(Choice A)</strong>.&nbsp; In addition, patients who confirm hopelessness along with other symptoms of postpartum depression should be screened for the presence of imminent risk (eg, <strong>suicidal ideation</strong>).&nbsp; If a patient is actively suicidal or has thoughts of harming the infant, hospitalization should be pursued.</p><p><strong>(Choice B)</strong>&nbsp; Postpartum blues is a self-limited condition with milder depressive symptoms that typically peak at 5 days postpartum and resolve within 2 weeks.&nbsp; However, this patient delivered 3 weeks ago, and her symptoms are more severe (eg, terminal insomnia, low energy, amotivation, impaired functioning), which requires further screening for postpartum depression and potentially treatment beyond &#x22;some coping strategies that may be helpful.&#x22;</p><p><strong>(Choices C and D)</strong>&nbsp; Maximizing restful sleep by obtaining additional childcare support and/or considering safe sleep medication options might be helpful for new mothers managing postpartum blues; however, assessing the patient for postpartum depression takes precedence because she would require more intensive treatment if positive.</p><p><strong>Educational objective:</strong><br>If left untreated, postpartum depression (ie, major depressive disorder with peripartum onset) can result in impaired maternal-infant bonding and increased risk for suicide and/or harm to the infant.&nbsp; New mothers with mood changes should be further assessed for postpartum depression.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Experiencing postpartum sleep and mood changes is common; would you be interested in talking to a counselor about how you&#39;ve been feeling?&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 924,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;It&#39;s common to have these symptoms for 1-2 weeks at the start of the postpartum period; let&#39;s talk about some coping strategies that may be helpful.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 1048,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;It&#39;s hard to rest and relax after you have a baby; what are your thoughts on finding an additional support person to help with childcare?&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 578,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Sleep is very important during the postpartum period; let&#39;s try a medication that&#39;s safe while breastfeeding so that you can get some rest.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 272,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Taking care of a baby is exhausting, and it can be difficult to find time for yourself; have you been experiencing any feelings of hopelessness?&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 13742,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2371,2685,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27570512",
                    "mediaDataId": 0,
                    "title": "Suicide during perinatal period: epidemiology, risk factors, and clinical correlates.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27570512",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 133,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 16564,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 358,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 14415,
            "questionIndex": 15824,
            "questionText": "<p>A 60-year-old woman with a history of locally advanced breast cancer comes to the office for scheduled follow-up.&nbsp; The patient underwent a lumpectomy followed by radiation therapy and completion of chemotherapy 6 months ago.&nbsp; She is currently taking an aromatase inhibitor.&nbsp; The patient feels that the fatigue she experienced during her chemotherapy has not improved.&nbsp; She has been sleeping poorly and recently left her volunteer job at the library because she is &#x22;too distracted to sit and alphabetize books.&#x22;&nbsp; The patient had previously been meeting weekly with friends for lunch but has not replied to recent invitations.&nbsp; Since her last appointment 3 months ago, she has lost 3 kg (6.6 lb); otherwise, vital signs are within normal limits, there are no changes on physical examination, and laboratory and imaging studies are unremarkable.&nbsp; When informed of these normal results, she says, &#x22;That&#39;s good to hear, but I&#39;m anxious that the cancer is coming back.&nbsp; Why else would I feel so tired all the time?&#x22;&nbsp; Which of the following is the most likely explanation of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>Although fatigue may persist after completion of chemotherapy, and anxiety about cancer recurrence is normal, this patient is showing other signs and symptoms that are concerning for <strong>major depressive disorder</strong> (MDD).&nbsp; She has loss of interest (eg, no longer meeting her friends for lunch),&nbsp;impaired concentration (eg, too distracted to alphabetize books), sleep disturbance, weight loss, and social isolation (eg, not responding to invitations)&nbsp;lasting &gt;2 weeks, strongly suggestive of MDD. &nbsp;This should prompt assessment of other depressive symptoms (eg, feelings of worthlessness/guilt, loss of self-esteem, suicidal ideation).</p><p>Recognition of <strong>major depression in medically ill patients</strong> is important because untreated depression can have a major impact on <strong>quality of life</strong> and can <strong>negatively affect treatment adherence</strong> and <strong>medical outcome</strong>.&nbsp; Physicians should not assume that depression is a normal reaction to a cancer diagnosis or that impairment in sleep, appetite, and energy level are due to the cancer or its treatment.&nbsp; Patients with cancer can be safely and effectively treated with psychotherapy and/or antidepressant medications.</p><p><strong>(Choice A)</strong>&nbsp; Although some of the patient&#39;s symptoms (eg, fatigue, cognitive problems) could be caused by an aromatase inhibitor, her anhedonia, poor sleep, and weight loss raise concern for MDD.&nbsp; Musculoskeletal symptoms (eg, arthralgia, joint stiffness, bone pain) and sexual dysfunction are the most common side effects of aromatase inhibitors.</p><p><strong>(Choice B)</strong>&nbsp; Depressive disorder due to another medical condition is only diagnosed when there is evidence that the mood disturbance is the direct result of another medical condition (eg, hypothyroidism, Parkinson disease).&nbsp; In the absence of any findings on physical examination or laboratory and imaging studies, this patient&#39;s depression is unlikely due to breast cancer recurrence or another undiagnosed medical condition.</p><p><strong>(Choice C)</strong>&nbsp; Illness anxiety disorder involves excessive fears of having a serious illness.&nbsp; It would not explain this patient&#39;s depressive symptoms, and her fear of breast cancer recurring is normal.</p><p><strong>(Choice E) </strong> This patient&#39;s symptoms are more severe than would be seen in a normal reaction and are causing significant distress and functional impairment.&nbsp; Further assessment and treatment are indicated.</p><p><strong>Educational objective:</strong><br>Diagnosing major depressive disorder in patients with cancer is difficult because somatic symptoms of depression (eg, fatigue, weight loss) may overlap with those of cancer and its treatment.&nbsp; If these symptoms are associated with depressed mood or loss of interest, major depressive disorder should be considered.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aromatase inhibitor side effects",
                    "choiceNumber": 1,
                    "correctTaken": 366,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Depressive disorder due to another medical condition",
                    "choiceNumber": 2,
                    "correctTaken": 1897,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Illness anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 1834,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 9868,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal reaction to cancer diagnosis and treatment",
                    "choiceNumber": 5,
                    "correctTaken": 1952,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1364,1513,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26118318",
                    "mediaDataId": 0,
                    "title": "Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26118318",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28973709",
                    "mediaDataId": 0,
                    "title": "Distinguishing depressive symptoms from similar cancer-related somatic symptoms: implications for assessment and management of major depression after breast cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28973709",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 174,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 15917,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 331,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 14569,
            "questionIndex": 15982,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 30 years<br><strong>Gender:</strong> F, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> emergency department</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> suicide attempt<br><strong>History of Present Illness:</strong><br>&#8226; brought in by ambulance<br>&#8226; patient&#39;s boyfriend found her sleeping next to a bottle of alprazolam; he had received a text from her that read: &#x22;I&#39;m not good enough for anyone.&nbsp; Goodbye.&#x22;<br>&#8226; patient reports taking 3 of the 1-mg tablets &#x22;with the hope of not waking up&#x22;<br>&#8226; boyfriend states she has been listless and sleeping until noon every day since he mentioned wanting to end their 4-year relationship 3 weeks ago<br><strong>Past Medical History:</strong><br>&#8226; depression &#x22;on and off&#x22; throughout her life; no prior suicide attempts<br>&#8226; boyfriend states, &#x22;She can be unusually upbeat and confident for days to weeks, and when she&#39;s like that she gets to work early in the morning, works until closing, and goes out for drinks and dancing until 2 in the morning.&#x22;<br><strong>Medications:</strong><br>&#8226; none<br><strong>Allergies:</strong><br>&#8226; no known drug allergies<br><strong>Family History:</strong><br>&#8226; noncontributory<br><strong>Psychosocial History:</strong><br>&#8226; retail worker<br>&#8226; drinks 3 or 4 glasses of wine a week; no other recreational substance use</p><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"Text-align:center;\"><tbody style=\"text-align:center\"><tr><td><strong>Temp</strong></td><td><strong>Pulse</strong></td><td><strong>Resp</strong></td><td><strong>BP</strong></td><td><strong>O</strong><font size=\"2\"><sub><strong>2</strong></sub></font>&nbsp;<strong>Sat</strong></td><td><strong>Ht</strong></td><td><strong>Wt</strong></td><td><strong>BMI</strong></td></tr><tr><td>37 C<br>(98.6 F)</td><td>70/min</td><td>14/min</td><td>118/70<br>mm Hg</td><td>&ndash;</td><td>&ndash;</td><td>&ndash;</td><td>20 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table><p>&#8226; Appearance: tearful; wearing oversized t-shirt and sweatpants; unkempt hair<br>&#8226; Pulmonary: clear lungs<br>&#8226; Cardiac: regular rate and rhythm; normal S<font size=\"2\"><sub>1</sub></font> and S<font size=\"2\"><sub>2</sub></font><br>&#8226; Abdominal: normal bowel sounds; soft and nontender<br>&#8226; Neurologic: alert and fully oriented; normal muscle tone; steady gait<br>&#8226; Mental status: mood is &#x22;depressed&#x22;; affect is constricted and minimally reactive; patient moves and speaks slowly; no suicidal ideation; she states, &#x22;I&#39;m glad my boyfriend found me.&#x22;</p><p><u><strong>Diagnostic Studies</strong></u><br>&#8226; none</p><p><u><strong>Question:</strong></u> Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38666\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Bipolar &amp; related disorders</strong></p></td></tr><tr><td><p><strong>Manic episode</strong></p><ul><li>Symptoms <strong>more severe</strong></li></ul><ul><li><strong>1 week</strong> unless hospitalized</li><li><strong>Marked impairment</strong> in social or occupational functioning or <strong>hospitalization</strong> necessary</li><li>May have <strong>psychotic features (</strong>makes episode manic by definition)</li></ul></td><td><p><strong>Hypomanic episode</strong></p><ul><li>Symptoms <strong>less severe</strong></li><li><strong>&ge;4 consecutive days</strong></li><li>Unequivocal, observable change in functioning from baseline</li><li>Symptoms not severe enough to cause marked impairment or necessitate hospitalization</li><li><strong>No psychotic features</strong></li></ul></td></tr><tr><td colspan=\"2\"><p><strong>Bipolar I</strong></p><ul><li><strong>Manic episode(s)</strong></li><li>Depressive episodes common but not required for diagnosis</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>Bipolar II</strong></p><ul><li><strong>Hypomanic episode(s)</strong></li><li>&ge;1 major depressive episodes</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>Cyclothymic disorder</strong></p><ul><li><strong>&ge;2 years</strong> of fluctuating, mild hypomanic &amp; depressive symptoms that do not meet criteria for hypomanic or major depressive episodes</li></ul></td></tr></tbody></table></div><p>This patient&#39;s current 3-week episode of <strong>depression</strong> and history suggestive of <strong>hypomanic episodes</strong> are most consistent with a diagnosis of <strong>bipolar II disorder</strong>.&nbsp; Her current depressive symptoms include depressed mood, suicidal ideation and attempt, loss of motivation/interest, hypersomnia, feeling of worthlessness, and psychomotor retardation.&nbsp; Evidence of past <strong>hypomanic episodes</strong> includes distinct periods lasting &#8805;4 days of <strong>elevated mood, increased energy</strong> and goal-directed activity, <strong>increased self-confidence</strong>, and <strong>decreased need for sleep</strong>.</p><p>Patients with bipolar II disorder do not experience full-blown manic episodes (ie, severe symptoms with marked functional impairment), making the differential diagnosis from other psychiatric disorders more difficult.&nbsp; Whereas patients in a manic episode frequently require inpatient treatment and may be psychotic, patients with hypomania are typically able to continue working.</p><p><strong>(Choice A)</strong>&nbsp; Although this patient&#39;s depression was precipitated by a stressor, adjustment disorder with depressed mood is not diagnosed when symptoms meet the diagnostic criteria for another mental disorder.</p><p><strong>(Choice C)</strong>&nbsp; The depressive and hypomanic episodes in bipolar II disorder may resemble the mood instability seen in borderline personality disorder.&nbsp; However, the labile mood states in borderline personality disorder are brief, typically lasting hours to days (rather than weeks to months).&nbsp; There is insufficient evidence to diagnose borderline personality disorder in this patient; she does not exhibit a lifelong pattern of identity disturbance, feelings of emptiness, intense anger, splitting, or self-mutilating behavior.</p><p><strong>(Choices D and E)</strong>&nbsp; Major depressive disorder and persistent depressive disorder (dysthymia) are unipolar disorders; these patients do not have hypomanic or manic episodes.&nbsp; Persistent depressive disorder is characterized by chronic depressive symptoms lasting &#8805;2 years.</p><p><strong>Educational objective:</strong><br>Bipolar II disorder is characterized by distinct episodes of major depression and hypomania.&nbsp; In contrast, the labile mood states seen in borderline personality disorder tend to fluctuate more rapidly.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with depressed mood",
                    "choiceNumber": 1,
                    "correctTaken": 50,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar disorder",
                    "choiceNumber": 2,
                    "correctTaken": 3964,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Borderline personality disorder",
                    "choiceNumber": 3,
                    "correctTaken": 938,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 57,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent depressive disorder",
                    "choiceNumber": 5,
                    "correctTaken": 55,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2070,2213,true,-1,1*2305,2447,true,-1,1*2620,2717,true,-1,1*93,119,true,-1,1*307,326,true,-1,1*472,493,true,-1,1*205,232,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28327444",
                    "mediaDataId": 0,
                    "title": "Unblending borderline personality and bipolar disorders.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28327444",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27611723",
                    "mediaDataId": 0,
                    "title": "The International Mood Network (IMN) Nosology Project: differentiating borderline personality from bipolar illness.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27611723",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24571137",
                    "mediaDataId": 0,
                    "title": "Bipolar or borderline: a clinical overview.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24571137",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 109,
            "othersAvgTimeSpent": 83,
            "notes": null,
            "peopleTaken": 5064,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 641,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 6931,
            "questionIndex": 6931,
            "questionText": "<p>A 30-year-old woman is brought to the office by her husband.&nbsp; He says that over the past 2 months, the patient has become increasingly depressed to the point that she rarely gets out of bed.&nbsp; She has called in sick to work, does not answer the phone when her friends call, and has lost 4.5 kg (10 lb).&nbsp; The patient has a history of 2 psychiatric hospitalizations.&nbsp; She was first hospitalized at age 27 for a period of extreme irritability and agitation that lasted a week.&nbsp; At that time, she spoke so rapidly that she was difficult to understand and stayed up for nights dictating letters to government officials about her solution to world hunger.&nbsp; Last year, the patient was hospitalized for severe depression and a suicide attempt.&nbsp; She responded within days to venlafaxine but discontinued the medication shortly after discharge because she &#x22;felt fine.&#x22;&nbsp; On mental status examination, the patient shows a depressed and tearful affect.&nbsp; She admits to &#x22;hearing the devil saying I&#39;m a useless waste of time.&#x22;&nbsp; Which of the following medications would be most appropriate for the long-term treatment of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient is currently experiencing symptoms of depression with psychotic features.&nbsp; Her history of mania, suggested by an episode of increased irritability, agitation, pressured speech, decreased need for sleep, and grandiosity, makes <strong>bipolar I disorder</strong> the most likely diagnosis.</p><p>Common options for <strong>maintenance treatment</strong> of bipolar disorder include <strong>lithium</strong> and <strong>valproate</strong>.&nbsp; The second-generation antipsychotic <strong>quetiapine</strong> and the anticonvulsant <strong>lamotrigine</strong> have also demonstrated efficacy.&nbsp; Lithium would be particularly helpful in this patient because it would reduce the risk of suicide.</p><p><strong>(Choice A)</strong>&nbsp; Clozapine is reserved for use in treatment-resistant schizophrenia due to the potential for life-threatening agranulocytosis.</p><p><strong>(Choices B, E, and F)</strong>&nbsp; Antidepressant monotherapy should be avoided in patients with bipolar I disorder due to the risk of mood destabilization.&nbsp; Fluoxetine, mirtazapine, and venlafaxine would be appropriate maintenance treatments for patients with recurrent, unipolar major depressive disorder but would risk inducing mania in this patient with bipolar I disorder.&nbsp; Her uncharacteristically rapid response to venlafaxine within a few days (typical time to response is 2-4 weeks) is another clue that she has bipolar disorder.</p><p><strong>(Choice C)</strong>&nbsp; Although haloperidol has a role in treating acute mania, particularly with psychotic features, it is not used for long-term management due to its side effect profile.</p><p><strong>Educational objective:</strong><br>Lithium, valproate, quetiapine, and lamotrigine are first-line maintenance treatments for bipolar disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Clozapine",
                    "choiceNumber": 1,
                    "correctTaken": 869,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fluoxetine",
                    "choiceNumber": 2,
                    "correctTaken": 221,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Haloperidol",
                    "choiceNumber": 3,
                    "correctTaken": 736,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lithium",
                    "choiceNumber": 4,
                    "correctTaken": 14330,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mirtazapine",
                    "choiceNumber": 5,
                    "correctTaken": 251,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Venlafaxine",
                    "choiceNumber": 6,
                    "correctTaken": 506,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "315,522,true,-1,1*524,622,true,-1,1*907,1287,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26523730",
                    "mediaDataId": 0,
                    "title": "Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26523730",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29188027",
                    "mediaDataId": 0,
                    "title": "Recent advances in the understanding and management of bipolar disorder in adults.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29188027",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 138,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 16913,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 85,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 361,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 3382,
            "questionIndex": 3382,
            "questionText": "<p>A 35-year-old man comes to the office due to poor sleep and feeling &#x22;worthless.&#x22;&nbsp; His insomnia and poor self-esteem began 2 months ago when he discovered that his girlfriend was romantically involved with one of her co-workers.&nbsp; The patient was very disappointed by this news as he thought he and his girlfriend were close and had a good sexual relationship.&nbsp; He immediately ended the relationship and has since stopped socializing, preferring instead to stay home alone.&nbsp; He admits to having little interest in dating women now, even when they seem to be a good match.&nbsp; Although the patient continues to meet his deadlines and fulfill all his professional responsibilities, he feels less motivated at work.&nbsp; He continues to go to the gym regularly, as exercising helps him &#x22;escape from feelings&#x22; he still has for his former girlfriend.&nbsp; He reluctantly admits to occasionally using marijuana to help him sleep.&nbsp; The patient has no psychiatric history.&nbsp; There is a family history of depression in his older sister, who was successfully treated with venlafaxine.&nbsp; Which of the following treatments is the most appropriate management for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33834\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Differential diagnosis of depressed mood </strong></p></td></tr><tr><td><p align=\"center\"><strong>Major depressive disorder </strong></p></td><td><ul><li>&ge;2 weeks</li><li><strong>&ge;5 of 9 </strong>symptoms: depressed mood &amp; SIGECAPS</li><li>Significant functional impairment</li><li>No lifetime history of mania</li></ul></td></tr><tr><td><p align=\"center\"><strong>Persistent depressive disorder (dysthymia) </strong></p></td><td><ul><li>Chronic depressed mood &ge;2 years</li><li>&ge;2 of the following: appetite disturbance, sleep disturbance, low energy, low self-esteem, poor concentration, hopelessness</li></ul></td></tr><tr><td><p align=\"center\"><strong>Adjustment disorder with depressed mood </strong></p></td><td><ul><li>Onset within 3 months of identifiable stressor</li><li>Marked distress &amp;/or functional impairment</li><li>Does not meet criteria for another DSM-5-TR&nbsp;disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Normal stress response </strong></p></td><td><ul><li>Not excessive or out of proportion to severity of stressor</li><li>No significant functional impairment</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SIGECAPS</strong> = <strong>S</strong>leep disturbance, loss of <strong>I</strong>nterest, excessive <strong>G</strong>uilt, low <strong>E</strong>nergy, impaired <strong>C</strong>oncentration, <strong>A</strong>ppetite disturbance, <strong>P</strong>sychomotor agitation/retardation, and <strong>S</strong>uicidal ideation.&nbsp;</p></td></tr></tbody></table></div><p>This patient&#39;s development of sleep disturbance, low self-esteem, and social isolation in response to the stress of a romantic breakup is consistent with an <strong>adjustment disorder</strong>.&nbsp; Adjustment disorder is characterized by emotional or behavioral symptoms that develop <strong>within 3 months</strong> of exposure to an <strong>identifiable stressor</strong> and rarely last more than 6 months after the stressor ends.&nbsp; Diagnosis requires evidence of <strong>significant distress or impairment</strong>, as seen in this patient&#39;s seeking help for his symptoms and social impairment.&nbsp; He lacks sufficient symptoms to meet the criteria for major depressive disorder as he does not have evidence of impaired concentration, low energy, appetite disturbance, psychomotor agitation or retardation, or suicidal ideation; therefore, the diagnosis of adjustment disorder is appropriate.</p><p>The <strong>treatment of choice</strong> for adjustment disorder is <strong>psychotherapy</strong>, which focuses on developing coping mechanisms and improving the individual&#39;s response to and attitude about the stressful situation.&nbsp; Helping this patient cope with his feelings of disappointment, improve his self-esteem, and eventually become open to new relationships would be appropriate.</p><p><strong>(Choices A, B, C, and E)</strong>&nbsp; The antidepressants bupropion, fluoxetine, mirtazapine, and venlafaxine would all be first-line pharmacologic treatment options if the patient met the criteria for major depressive disorder.&nbsp; Bupropion has the advantage of not causing sexual side effects but can be activating and worsen insomnia.&nbsp; If the patient develops major depression, the serotonin-norepinephrine reuptake inhibitor venlafaxine could be considered given the history of a positive response in a first-degree relative.</p><p><strong>(Choice F)</strong>&nbsp; Zolpidem is a nonbenzodiazepine hypnotic used to treat insomnia.&nbsp; Targeting this patient&#39;s sleep disturbance alone would not adequately address his adjustment disorder.</p><p><strong>Educational objective:</strong><br>Adjustment disorder involves symptoms causing marked distress and impairment that develop within 3 months in response to a stressor.&nbsp; It is not diagnosed if symptoms meet the criteria for another specific disorder (eg, major depressive disorder).&nbsp; The treatment of choice is psychotherapy that focuses on improving coping skills and promoting a return to functioning.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 396,
            "topic": "Adjustment disorders",
            "titleId": 396,
            "title": "Adjustment disorders",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bupropion",
                    "choiceNumber": 1,
                    "correctTaken": 299,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fluoxetine",
                    "choiceNumber": 2,
                    "correctTaken": 3270,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mirtazapine",
                    "choiceNumber": 3,
                    "correctTaken": 913,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Psychotherapy",
                    "choiceNumber": 4,
                    "correctTaken": 10287,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Venlafaxine",
                    "choiceNumber": 5,
                    "correctTaken": 1193,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Zolpidem",
                    "choiceNumber": 6,
                    "correctTaken": 1105,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "186,214,true,-1,1*259,290,true,-1,1*291,313,true,-1,1*402,414,true,-1,1*365,380,true,-1,1*2299,2405,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19558652",
                    "mediaDataId": 0,
                    "title": "Adjustment disorder: epidemiology, diagnosis and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19558652",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 161,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 17073,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1176,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 14518,
            "questionIndex": 15928,
            "questionText": "<p>A 19-year-old woman is brought to the emergency department by the police after she was found trespassing at an animal shelter.&nbsp; The patient had keys to a rental van, as well as numerous collars and leashes.&nbsp; She says, &#x22;The shelter is going to sell the animals to labs, where they&#39;ll do horrible experiments on them.&nbsp; I&#39;m the only one who can save them!&#x22;&nbsp; The patient quit her retail job a week ago to spend more time researching escape routes for the animals.&nbsp; Throughout the evaluation, she interrupts the physician to yell at other patients and hospital staff walking by the room.&nbsp; She repeatedly refers to herself as a &#x22;cat burglar&#x22; and then laughs loudly for a few minutes.&nbsp; Physical examination is unremarkable and urine drug screening is negative.&nbsp; Which of the following additional features is most likely in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34762\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Manic episode</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>&ge;1 week of elevated or irritable mood &amp; increased energy/activity</li><li>&ge;3 of the following symptoms (4 if mood is irritable only) (DIGFAST mnemonic):<ul style=\"list-style-type:circle;\"><li>Distractibility</li><li>Impulsivity/indiscretion, risky behavior</li><li>Grandiosity</li><li>Flight of ideas/racing thoughts</li><li>Increased activity/psychomotor agitation</li><li>Decreased need for sleep</li><li>Talkativeness/pressured speech</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Severity</strong></p></td><td><ul><li>Impaired psychosocial function</li><li>May have psychotic features (hallucinations, delusions)</li><li>May require hospitalization</li></ul></td></tr></tbody></table></div><p>This patient&#39;s recent history of abnormal mood, impulsive, risky behavior, and grandiosity (ie, belief that only she can save the animals), as well as findings of loud speech, distractibility, and inappropriate joking and laughter on mental status examination, are characteristic of a <strong>manic episode</strong> of <strong>bipolar I disorder</strong>.&nbsp; Patients with mania are often expansive and disinhibited, interacting with strangers without regard to social conventions (eg, yelling at others walking by).&nbsp; Impaired judgment is common, as with this patient abruptly quitting her job and trespassing at the animal shelter.</p><p>A <strong>key feature</strong> of mania is <strong>decreased need for sleep</strong> due to increased energy.&nbsp; This is differentiated from insomnia, which refers to difficulty sleeping despite feeling tired.&nbsp; Patients in a manic episode may sleep only a few hours or go without sleep entirely for several days.&nbsp; Despite lack of sleep, they feel well rested and energetic.&nbsp; Mania typically has an acute onset with rapid progression over a few days, resulting in marked impairment in functioning.&nbsp; Hospitalization may be necessary to protect the patient from further destructive behaviors.</p><p><strong>(Choice A)</strong>&nbsp; Although psychotic features (eg, delusions, hallucinations) may develop during a manic episode, tactile hallucinations (eg, bugs crawling on the skin) are uncommon.&nbsp; Tactile hallucinations are most commonly associated with substance use disorders or medical conditions.</p><p><strong>(Choice B)</strong>&nbsp; Having intrusive, unwanted thoughts is a core feature of obsessive-compulsive disorder.&nbsp; Although this patient is intensely preoccupied with saving animals, her thoughts are not experienced as intrusive or disturbing, and her behavior is consistent with the increased activity commonly seen in mania.</p><p><strong>(Choice C)</strong>&nbsp; A feeling of detachment is a dissociative symptom more commonly seen in patients with posttraumatic stress disorder.</p><p><strong>(Choices E and F)</strong>&nbsp; Neglecting personal grooming and increased latency of response are examples of negative symptoms, which are a characteristic feature of schizophrenia, not bipolar disorder.</p><p><strong>Educational objective:</strong><br>Core features of a manic episode include elevated or irritable mood, increased energy/activity, and a decreased need for sleep.&nbsp; Manic patients may feel rested and energetic despite getting very little or no sleep.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Experiencing a sensation of bugs crawling on skin",
                    "choiceNumber": 1,
                    "correctTaken": 208,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Experiencing intrusive, unwanted thoughts",
                    "choiceNumber": 2,
                    "correctTaken": 1027,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Feeling a sense of detachment from self and the environment",
                    "choiceNumber": 3,
                    "correctTaken": 335,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Feeling well rested despite minimal sleep",
                    "choiceNumber": 4,
                    "correctTaken": 12893,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neglecting personal grooming",
                    "choiceNumber": 5,
                    "correctTaken": 3167,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pausing for long periods prior to responding to questions",
                    "choiceNumber": 6,
                    "correctTaken": 247,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "62,204,true,-1,1*445,500,true,-1,1*1126,1298,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29630220",
                    "mediaDataId": 0,
                    "title": "Mania.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29630220",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28888714",
                    "mediaDataId": 0,
                    "title": "The diagnosis and management of bipolar I and II disorders: clinical practice update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28888714",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26388529",
                    "mediaDataId": 0,
                    "title": "Bipolar disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26388529",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 81,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 17877,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1043,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 11141,
            "questionIndex": 12287,
            "questionText": "<p>A 52-year-old man with a history of schizoaffective disorder is admitted to the hospital for treatment of a lower extremity cellulitis.&nbsp; The patient does not appear to have any other acute medical illness.&nbsp; He is continued on his home medications&mdash;lithium, risperidone, and sertraline&mdash;and cephalosporin therapy is initiated to treat his infection.&nbsp; During the hospital stay, the patient also receives ibuprofen and acetaminophen for pain and lorazepam as needed for anxiety and insomnia.&nbsp; His infection improves over the next 10-14 days, but prior to discharge, he develops repeated episodes of vomiting and diarrhea.&nbsp; At the same time, the patient becomes tremulous and uncoordinated, which makes it difficult for him to walk without falling.&nbsp; In addition, he seems confused.&nbsp; Vital signs are normal.&nbsp; Physical examination shows fasciculations and bilateral tremor.&nbsp; Which of the following medications is most likely to have caused this patient&#39;s new symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42583\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\" style=\"width: 100%;\"><p align=\"center\"><strong>Lithium toxicity</strong></p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Etiology</strong></p></td><td style=\"width: 75%;\"><p>Acute toxicity</p><ul><li>Intentional overdose</li></ul><p>Chronic toxicity</p><ul><li>Decreased renal perfusion (&darr; lithium clearance)<ul style=\"list-style-type:circle;\"><li>Dehydration</li><li>Thiazide diuretics, NSAIDs, ACE inhibitors</li></ul></li></ul></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width: 75%;\"><p>Acute toxicity</p><ul><li>Gastrointestinal: nausea, vomiting, diarrhea</li><li>Late neurologic sequelae</li></ul><p>Chronic toxicity (neurologic)</p><ul><li>Lethargy, confusion, agitation</li><li>Ataxia, tremor/fasciculations, seizure</li></ul></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width: 75%;\"><ul><li>Intravenous hydration</li><li>Hemodialysis (severe cases)</li></ul></td></tr><tr><td colspan=\"2\" style=\"width: 100%;\"><p><strong>NSAID</strong> = nonsteroidal anti-inflammatory drug.</p></td></tr></tbody></table></div><p>The new onset of severe <strong>gastrointestinal symptoms</strong>, <strong>confusion</strong>, <strong>ataxia</strong>, and <strong>tremor</strong> (and other symptoms of neuromuscular irritability) in a patient taking lithium suggests <strong>lithium toxicity</strong>.&nbsp; Lithium is a mood stabilizer used to treat bipolar disorder and schizoaffective disorder (bipolar type).&nbsp; It has a narrow therapeutic index and relies on adequate kidney function for its excretion.&nbsp; This patient likely developed lithium toxicity due to a drug interaction with ibuprofen.&nbsp; Concurrent use of <strong>nonsteroidal anti-inflammatory drugs</strong>&nbsp;(eg, ibuprofen) can cause a decrease in renal clearance of lithium and lead to elevated serum lithium levels and lithium toxicity.&nbsp; Other drugs that increase lithium levels include thiazide diuretics, ACE inhibitors, tetracyclines, and metronidazole.</p><p><strong>(Choice A)</strong>&nbsp; Acetaminophen may cause gastrointestinal symptoms and hepatic toxicity.&nbsp; However, it is not likely to cause adverse neurological effects such as ataxia, fasciculations, or tremor.</p><p><strong>(Choice C)</strong>&nbsp; Lorazepam toxicity may cause sedation, confusion, and gait disturbance.&nbsp; However, it would not lead to fasciculations and bilateral tremor.&nbsp; Alternatively, lorazepam withdrawal is unlikely to occur after 10-14 days of as-needed use.</p><p><strong>(Choice D)</strong>&nbsp; Risperidone, a second-generation antipsychotic, may cause galactorrhea, orthostasis, metabolic syndrome, and extrapyramidal symptoms.&nbsp; Gastrointestinal symptoms are unlikely.&nbsp; In rare cases, risperidone can cause neuroleptic malignant syndrome, characterized by autonomic instability, high fevers, delirium, and muscle rigidity.</p><p><strong>(Choice E)</strong>&nbsp; Sertraline, a selective serotonin reuptake inhibitor, may cause gastrointestinal symptoms, fasciculations, and tremor.&nbsp; However, it is unlikely to lead to confusion or ataxia in therapeutic doses.&nbsp; If combined with other serotonergic drugs, it can lead to serotonin syndrome, which is characterized by mental status changes, autonomic instability, hyperthermia, and neuromuscular irritability.</p><p><strong>Educational objective:</strong><br>The addition of nonsteroidal anti-inflammatory drugs (or thiazide diuretics, ACE inhibitors, tetracyclines, and metronidazole) to lithium can increase serum lithium levels and lead to symptoms of toxicity, including gastrointestinal symptoms, confusion, ataxia, and tremor.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 14210,
            "topic": "Lithium",
            "titleId": 14210,
            "title": "Lithium",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acetaminophen",
                    "choiceNumber": 1,
                    "correctTaken": 410,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lithium",
                    "choiceNumber": 2,
                    "correctTaken": 8875,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lorazepam",
                    "choiceNumber": 3,
                    "correctTaken": 1449,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Risperidone",
                    "choiceNumber": 4,
                    "correctTaken": 2193,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline",
                    "choiceNumber": 5,
                    "correctTaken": 1229,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "109,211,true,-1,1*230,414,true,-1,1*707,811,true,-1,1*1183,1301,true,-1,1*1809,1887,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26936045",
                    "mediaDataId": 0,
                    "title": "Drug interactions with lithium: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26936045",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24579242",
                    "mediaDataId": 0,
                    "title": "Drug-related admissions due to interaction with an old drug, lithium.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24579242",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 91,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 14156,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1907,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 14435,
            "questionIndex": 15844,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 27 years<br><strong>Gender:</strong> M, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> office</p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> &#x22;I feel hopeless.&#x22;<p><strong>History of Present Illness:</strong></p><ul style=\"padding-left: 1.2em; margin-top:-15px;\"><li>depressed mood and feeling of worthlessness following breakup with his girlfriend 6 weeks ago</li><li>feels tired despite sleeping 12 hours a day</li><li>difficulty completing daily activities like showering and getting dressed</li><li>unable to concentrate on anything; spends time flipping through television channels to distract himself from feeling sad</li></ul><p><strong>Past Medical History:</strong></p><ul style=\"padding-left: 1.2em; margin-top:-15px;\"><li>multiple depressive episodes starting at age 17; suicide attempt at age 22; no history of antidepressant trial</li><li>psychotic episode at age 25, in which the patient believed he was a renowned sea captain; spent savings buying a boat and stayed up for days recruiting others for his expedition; symptoms fully resolved with inpatient treatment; patient did not follow up and discontinued medication shortly after discharge</li></ul><p><strong>Medications:</strong></p><ul style=\"padding-left: 1.2em; margin-top:-15px;\"><li>none</li></ul><p><strong>Allergies:</strong></p><ul style=\"padding-left: 1.2em; margin-top:-15px;\"><li>no known drug allergies</li></ul><p><strong>Family History:</strong></p><ul style=\"padding-left: 1.2em; margin-top:-15px;\"><li>noncontributory</li></ul><p><strong>Psychosocial History:</strong></p><ul style=\"padding-left: 1.2em; margin-top:-15px;\"><li>plumber</li><li>drinks 4 or 5 beers a week; no other recreational substance use</li></ul><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody style=\"text-align:center\"><tr><td><strong>Temp</strong></td><td><strong>Pulse</strong></td><td><strong>Resp</strong></td><td><strong>BP</strong></td><td><strong>O Sat</strong></td><td><strong>Ht</strong></td><td><strong>Wt</strong></td><td><strong>BMI</strong></td></tr><tr style=\"text-align:center;\"><td style=\"vertical-align:top;\">37 C<br>(98.6 F)</td><td style=\"vertical-align:top;\">88/min</td><td style=\"vertical-align:top;\">15/min</td><td style=\"vertical-align:top;\">114/76<br>mm Hg</td><td style=\"vertical-align:top;\">99%<br>on RA</td><td style=\"vertical-align:top;\">&ndash;</td><td style=\"vertical-align:top;\">&ndash;</td><td style=\"vertical-align:top;\">21 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table>&nbsp;<ul style=\"padding-left: 1.2em;\"><li>Appearance: dressed casually with wrinkled shirt; tearful when discussing breakup</li><li>Pulmonary: clear lungs</li><li>Cardiac: regular rate and rhythm; normal S<font size=\"2\"><sub>1</sub></font> and S<font size=\"2\"><sub>2</sub></font></li><li>Abdominal: normal bowel sounds; soft and nontender; no hepatosplenomegaly</li><li>Neurologic: alert and fully oriented</li><li>Mental status: slow rate of speech with moderate response latency; patient states, &#x22;I can&#39;t live without my girlfriend&#x22; but has no suicidal thoughts; does not appear to be internally preoccupied</li></ul><p><u><strong>Diagnostic Studies</strong></u></p><ul style=\"padding-left: 1.2em; margin-top:-15px;\"><li>none</li></ul><p><u><strong>Question:</strong></u> Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T49590\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Mood disorders with psychotic features vs primary psychotic disorders</strong></p></td></tr><tr><td><p align=\"center\"><strong>Major depressive or bipolar disorder with psychotic features</strong></p></td><td><ul><li>Psychotic symptoms occur exclusively during mood episodes</li></ul></td></tr><tr><td><p align=\"center\"><strong>Schizophrenia</strong></p></td><td><ul><li>Mood symptoms, if present, are brief &amp; not prominent</li></ul></td></tr><tr><td><p align=\"center\"><strong>Schizoaffective disorder</strong></p></td><td><ul><li>Major depressive or manic episode occurs concurrently with symptoms of schizophrenia</li><li>Patient has a lifetime history of delusions or hallucinations for &#8805;2 weeks outside of mood episode</li><li>Mood episodes are prominent &amp; recur throughout illness</li></ul></td></tr></tbody></table></div><p>All patients who have depression should be screened for a history of mania to differentiate unipolar from bipolar disorders.&nbsp; This patient&#39;s current symptoms of a <strong>major depressive episode</strong> and <strong>history of a manic episode</strong> are consistent with <strong>bipolar I disorder</strong>.&nbsp; His depressive symptoms include depressed mood, feeling of worthlessness, hypersomnia, low energy/lethargy, and psychomotor retardation (ie, slow rate of speech with latency) on mental status examination.&nbsp; The patient&#39;s history of a psychotic episode 2 years ago, characterized by grandiose delusions, decreased need for sleep, and impulsive spending, is characteristic of a manic episode with psychotic features.</p><p>Patients with bipolar I disorder may have psychotic symptoms (eg, delusions, hallucinations) when they experience severe manic and depressive episodes.&nbsp; The <strong>absence of psychotic symptoms outside of mood episodes</strong>, as in this patient who is psychotic only when he is manic, rules out primary psychotic disorders.</p><p><strong>(Choice A)</strong>&nbsp; Although the patient&#39;s current depressive episode was triggered by a romantic breakup, adjustment disorder is not diagnosed when symptoms are severe enough to meet criteria for another psychiatric disorder such as bipolar disorder.</p><p><strong>(Choice C)</strong>&nbsp; Patients with borderline personality disorder commonly experience mood swings in reaction to<s> </s>interpersonal stressors.&nbsp; However, a personality disorder would not adequately explain this patient&#39;s recurrent manic and depressive episodes, and he lacks key borderline personality features such as unstable identity and repetitive self-harm.</p><p><strong>(Choice D)</strong>&nbsp; Major depressive disorder is characterized by major depressive episodes and no history of mania.</p><p><strong>(Choice E)</strong>&nbsp; Schizoaffective disorder is a primary psychotic disorder characterized by psychotic symptoms that occur independently of mood episodes.&nbsp; This patient&#39;s psychotic symptoms occurred solely when he was clearly manic and completely resolved with treatment of his manic episode.&nbsp; Diagnostic criteria for schizoaffective disorder include a history of &#8805;2 weeks of psychotic symptoms in the absence of a mood episode.</p><p><strong>Educational objective:</strong><br>Bipolar disorder is characterized by depressive and manic episodes.&nbsp; If psychotic symptoms occur, they are present only in the context of a manic or major depressive episode.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with depressed mood",
                    "choiceNumber": 1,
                    "correctTaken": 897,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar disorder",
                    "choiceNumber": 2,
                    "correctTaken": 12597,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Borderline personality disorder",
                    "choiceNumber": 3,
                    "correctTaken": 157,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 1878,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizoaffective disorder",
                    "choiceNumber": 5,
                    "correctTaken": 1406,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "396,494,true,-1,1*1376,1534,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30933689",
                    "mediaDataId": 0,
                    "title": "Unrecognized bipolar disorder in patients with depression managed in primary care: a systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30933689",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25134871",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of bipolar disorder in primary care: a DSM-5 update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25134871",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 152,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16935,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1013,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 14485,
            "questionIndex": 15894,
            "questionText": "<p>An 11-year-old boy is brought to the office by his mother for assessment of behavioral issues.&nbsp; His mother explains that he has &#x22;not been himself&#x22; since starting middle school a few months ago.&nbsp; The patient has become increasingly argumentative with his parents and becomes irritable with his siblings for no clear reason.&nbsp; He spends most of his time in his bedroom and comes out only to eat dinner, quickly returning to his room after only a few bites.&nbsp; He watches TV late into the night due to restlessness, struggles to fall asleep, and then complains that he is tired the next day.&nbsp; The patient used to regularly attend soccer practice and spend time with friends afterward but recently said that he is &#x22;bad at&#x22; the sport and wants to quit the team.&nbsp; A teacher has expressed concern that his grades have dropped from a B to a C average, that he is not engaged in class, and that his work has become &#x22;sloppy.&#x22;&nbsp; When interviewed without his mother present, the patient says, &#x22;I just wish people would leave me alone.&#x22;&nbsp; The patient does not use alcohol or illicit drugs.&nbsp; Vital signs are normal, and physical examination shows no abnormalities.&nbsp; He makes poor eye contact and fidgets with his clothes.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This pediatric patient&#39;s behavioral changes, marked by an <strong>irritable mood</strong> and withdrawal from social activities together with poor <strong>sleep</strong>, poor <strong>appetite</strong>, impaired <strong>concentration</strong>, and psychomotor <strong>agitation</strong> (restlessness, fidgeting), are consistent with <strong>major depressive disorder (MDD)</strong>.</p><p>As children move into adolescence and explore their autonomy and identity, they may engage in limit-testing and a desire to spend time with peers rather than family.&nbsp; However, a marked change from baseline, with <strong>social withdrawal</strong> from peers and <strong>declining academic</strong> performance, as in this case, should prompt concern for a primary psychiatric illness and not be dismissed as age-appropriate behavior <strong>(Choice E)</strong>.&nbsp; Pediatric depression may present with symptoms of irritability, annoyance, and argumentative behavior rather than depressed mood.&nbsp; Identification and appropriate treatment are important to decrease distress and limit impairment in social, emotional, and academic development, as well as to decrease the risk of suicide.</p><p><strong>(Choice A)</strong>&nbsp; Although starting middle school can be a significant stressor, the severity of symptoms and degree of impairment in this patient make MDD more likely than adjustment disorder.&nbsp; Adjustment disorder&nbsp;is not diagnosed when the criteria for another psychiatric disorder, such as MDD, are met.</p><p><strong>(Choice B)</strong>&nbsp; Attention-deficit hyperactivity disorder would not explain this patient&#39;s poor sleep, poor appetite, or social withdrawal.&nbsp; Impaired concentration, distractibility, and psychomotor changes (agitation in this case) are common manifestations of depression.</p><p><strong>(Choice C)</strong>&nbsp; In disruptive mood dysregulation disorder, patients also have irritable mood.&nbsp; However, this is accompanied by repetitive temper outbursts (verbal or physical) that are out of proportion to the stimulus and inconsistent with developmental level.&nbsp; Symptoms manifest prior to age 10.</p><p><strong>(Choice F)</strong>&nbsp; Oppositional defiant disorder presents with an irritable or angry mood accompanied by deliberately annoying behavior, defiance of rules, and vindictiveness.&nbsp; It would not explain poor sleep, poor appetite, or social withdrawal.&nbsp; This child&#39;s defiance is likely a result of his irritability rather than being deliberate in nature.</p><p><strong>Educational objective:</strong><br>Pediatric major depression may present with irritability rather than depressed mood.&nbsp; If a patient displays irritability along with social withdrawal and academic decline, major depression should be considered.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 11037,
            "topic": "Child and adolescent mental health",
            "titleId": 11037,
            "title": "Child and adolescent mental health",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with mixed disturbance of emotions and conduct",
                    "choiceNumber": 1,
                    "correctTaken": 4785,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Attention-deficit hyperactivity disorder",
                    "choiceNumber": 2,
                    "correctTaken": 630,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disruptive mood dysregulation disorder",
                    "choiceNumber": 3,
                    "correctTaken": 870,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 9103,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal, age-appropriate behavior",
                    "choiceNumber": 5,
                    "correctTaken": 1371,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oppositional defiant disorder",
                    "choiceNumber": 6,
                    "correctTaken": 284,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "210,258,true,-1,1*1622,1904,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26858097",
                    "mediaDataId": 0,
                    "title": "Screening for depression in children and adolescents: U.S. Preventive Services Task Force recommendation statement.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26858097",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 105,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 17043,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 686,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 14573,
            "questionIndex": 15986,
            "questionText": "<p>A 31-year-old woman is brought to the emergency department by her boyfriend&nbsp;due to confusion.&nbsp; The boyfriend&nbsp;says that the patient &#x22;seemed okay&#x22; when he left for work this morning, but when he returned in the evening, she was disoriented and &#x22;acting like a drunk person&#x22;; she had also vomited &#x22;all over the bathroom.&#x22;&nbsp; The patient was recently fired due to interpersonal problems with other employees.&nbsp; She has a history of bipolar disorder.&nbsp; Medications include clonazepam, lithium, and quetiapine.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 110/68 mm Hg, pulse is 92/min, and respirations are 16/min.&nbsp; On physical examination, the patient is somnolent and has frequent fasciculations.&nbsp; Pupils are equal and reactive.&nbsp; During evaluation, she has a brief episode of a generalized tonic-clonic seizure.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">13 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">300,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">9,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td style=\"vertical-align:middle;\">136 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td style=\"vertical-align:middle;\">3.8 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td style=\"vertical-align:middle;\">28 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">1.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">120 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Blood alcohol</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Serum lithium</td><td style=\"vertical-align:middle;\">2.8 mEq/L (therapeutic range: 0.6-1.2)</td></tr></tbody></table><p>Acetaminophen and salicylate are not detected in the serum, and urine drug screen is negative.&nbsp; A noncontrast CT scan of the head shows no abnormalities.&nbsp; In addition to supportive measures, which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient is experiencing acute <strong>lithium toxicity</strong>.&nbsp; <strong>Neurologic</strong> (eg, altered mental status, seizure, fasciculations, tremor) and <strong>gastrointestinal</strong> (eg, vomiting, diarrhea) <strong>signs</strong> are common in cases of acute intoxication.&nbsp; Although mild overdoses can frequently be managed supportively with hydration and monitoring, <strong>hemodialysis</strong> is the treatment of choice for patients with lithium levels &gt;2.5 mEq/L and prominent signs of toxicity.&nbsp; Patients with levels &gt;4 mEq/L and creatinine &gt;2.0 mg/dL should generally be prescribed dialysis regardless of symptoms.</p><p>Because lithium is renally excreted, common precipitants of toxicity include medications that affect the excretion rate (eg, nonsteroidal anti-inflammatory drugs, ACE inhibitors, angiotensin receptor blockers) as well as dehydration by any cause (eg, diuretics, gastrointestinal illness).&nbsp; Intentional overdose should also always be on the differential.</p><p><strong>(Choices A and D)</strong>&nbsp; Activated charcoal does not absorb cations such as lithium, and gastric lavage is ineffective for lithium toxicity.</p><p><strong>(Choices B and F)</strong>&nbsp; Calcium gluconate may be used in cases of hypocalcemia and hyperkalemia.&nbsp; Magnesium sulfate is used in the treatment of hypomagnesemia, torsade de pointes, and preeclampsia.&nbsp; They have no indication for use in lithium toxicity.</p><p><strong>(Choice C)</strong>&nbsp; Flumazenil, a selective GABA-A antagonist, is an antidotal therapy for benzodiazepine overdose but is rarely used because of the risk of seizures.&nbsp; Manifestations of benzodiazepine overdose include slurred speech, ataxia, and depressed mental status with normal vital signs; fasciculations and gastrointestinal symptoms would be uncommon.</p><p><strong>(Choice G)</strong>&nbsp; Physostigmine is an acetylcholinesterase inhibitor used as antidotal therapy for anticholinergic poisoning.&nbsp; Anticholinergic poisoning can cause confusion (eg, mad as a hatter) but would also cause vasodilation (eg, red as a beet), anhidrosis (eg, dry as a bone), nonreactive mydriasis (eg, blind as a bat), and hallucinations (eg, mad as a hatter) with tachycardia and absent/decreased bowel sounds.</p><p><strong>Educational objective:</strong><br>Lithium toxicity presents with neurologic (eg, altered mental status, seizure, fasciculations, tremor) and gastrointestinal (eg, vomiting, diarrhea) signs.&nbsp; The treatment of choice is hemodialysis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 14210,
            "topic": "Lithium",
            "titleId": 14210,
            "title": "Lithium",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Activated charcoal",
                    "choiceNumber": 1,
                    "correctTaken": 684,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Calcium gluconate",
                    "choiceNumber": 2,
                    "correctTaken": 578,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Flumazenil",
                    "choiceNumber": 3,
                    "correctTaken": 572,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gastric lavage",
                    "choiceNumber": 4,
                    "correctTaken": 420,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemodialysis",
                    "choiceNumber": 5,
                    "correctTaken": 7861,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate",
                    "choiceNumber": 6,
                    "correctTaken": 1017,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Physostigmine",
                    "choiceNumber": 7,
                    "correctTaken": 69,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "251,583,true,-1,1*1166,1265,true,-1,1*1331,1373,true,-1,1*1460,1479,true,-1,1*1947,1968,true,-1,1*1994,2011,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25583292",
                    "mediaDataId": 0,
                    "title": "Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP Workgroup.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25583292",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27516079",
                    "mediaDataId": 0,
                    "title": "Lithium poisoning.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27516079",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 90,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 11201,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 613,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 14567,
            "questionIndex": 15980,
            "questionText": "<p>A 15-year-old girl comes to the office with her mother for follow-up 1 week after a prolonged hospitalization for an acute asthma exacerbation.&nbsp; The patient is taking inhaled albuterol and an oral corticosteroid, and her respiratory symptoms have improved significantly.&nbsp; Her mother states that since hospital discharge, the girl has been acting strangely.&nbsp; She is &#x22;talking over people instead of listening&#x22; and is unable to sit still.&nbsp; The patient also has started to ignore requests to complete her daily chores and has been refusing dinner because she is &#x22;too busy&#x22; with organizing a school club for environmental protection.&nbsp; She says she has been under a lot of pressure due to upcoming final exams but now feels &#x22;better than ever,&#x22; explaining how she will have more time to &#x22;save the oceans and Mother Earth&#x22; after she is done studying.&nbsp; The patient has a history of depression and takes sertraline.&nbsp; She has used marijuana occasionally but does not use tobacco, alcohol, or other illicit drugs.&nbsp; Vital signs are within normal limits, and cardiopulmonary examination shows no abnormalities.&nbsp; The patient appears impatient and checks her watch frequently throughout the evaluation.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s acute onset of <strong>hypomanic symptoms</strong> that include elevated mood, hyperactivity, talkativeness, goal-directed activity, and grandiosity (believing she can save the earth) in the context of <strong>corticosteroid use</strong> is suggestive of a <strong>medication-induced mood disorder</strong>.&nbsp; In the case of new-onset psychiatric symptoms, it is essential to rule out medical and substance-induced causes.&nbsp; This patient&#39;s symptoms developed suddenly after a prolonged hospitalization for an asthmatic episode in which high-dose corticosteroids were likely administered.</p><p>The psychiatric and cognitive effects of <strong>glucocorticoids</strong> may be mild and include euphoria, irritability, restlessness, anxiety, and sleep disturbance.&nbsp; Severe effects are more common with high doses or prolonged use and include <strong>depression</strong>, hypomania (as in this case) or <strong>mania</strong>, <strong>psychosis</strong>, and confusion.&nbsp; Mood symptoms typically resolve after the offending agent is discontinued.</p><p><strong>(Choice A)</strong>&nbsp; Acute stress disorder is characterized by symptoms of intrusive re-experiencing, avoidance, dissociation, and arousal lasting for &#8804;4 weeks in response to a traumatic event.</p><p><strong>(Choice B)</strong>&nbsp; Adjustment disorder is diagnosed when an individual responds to a stressor with an emotional and/or behavioral disturbance that does not meet criteria for a more specific disorder, such as medication-induced mood disorder (as in this patient).</p><p><strong>(Choices C and D)</strong>&nbsp; Diagnosis of bipolar II and related primary psychiatric disorders requires that hypomania not be caused by substances or medication.&nbsp; Cyclothymia requires a duration of &#8805;1 year in adolescents (&#8805; 2 years in adults) and involves cyclical mood disturbances that do not meet all criteria for a full-blown depressive or hypomanic episode.&nbsp; The diagnosis of bipolar II disorder requires &#8805;1 hypomanic episode and &#8805;1 depressive episode.</p><p><strong>(Choice F)</strong>&nbsp; Although adolescents may be impulsive, overconfident, and limit-testing, this girl&#39;s acute onset of behavioral changes representing a marked change from her baseline is more likely due to a medication-induced mood disorder.</p><p><strong>Educational objective:</strong><br>Evaluation of new-onset mood symptoms requires that medical and substance-induced causes be ruled out.&nbsp; The neuropsychiatric side effects of glucocorticoids include euphoria, depression, hypomania or mania, and psychosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24164,
            "topic": "Substance induced mood disorder",
            "titleId": 24164,
            "title": "Substance induced mood disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute stress disorder",
                    "choiceNumber": 1,
                    "correctTaken": 214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 2,
                    "correctTaken": 102,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar II disorder",
                    "choiceNumber": 3,
                    "correctTaken": 5015,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cyclothymic disorder",
                    "choiceNumber": 4,
                    "correctTaken": 174,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication-induced mood disorder",
                    "choiceNumber": 5,
                    "correctTaken": 11196,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal adolescent behavior",
                    "choiceNumber": 6,
                    "correctTaken": 393,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "732,959,true,-1,1*1555,1634,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25272344",
                    "mediaDataId": 0,
                    "title": "Adverse consequences of&#160;glucocorticoid&#160;medication: psychological, cognitive, and behavioral effects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25272344",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22764363",
                    "mediaDataId": 0,
                    "title": "Suicidal behavior and severe neuropsychiatric disorders following&#160;glucocorticoid&#160;therapy in primary care.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22764363",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 94,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 17094,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 418,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 11247,
            "questionIndex": 12402,
            "questionText": "<p>A 32-year-old man is brought to the emergency department after falling from a fourth-floor balcony of his apartment building.&nbsp; A witness at the scene reported that the patient stood on the balcony ledge for several minutes beforehand, looking down toward the street.&nbsp; His fall was broken by a tree, and he sustained multiple minor injuries, including abrasions and lacerations to his face and the extremities.&nbsp; The patient explains that he had a couple of beers and lost his balance while he was birdwatching.&nbsp; He has no medical history but reports that he has lost some weight and feels tired because he cannot sleep due to the loud street noise in his neighborhood.&nbsp; He lives alone and is worried about not being able to pay the rent if he does not find work soon.&nbsp; The patient drinks 3 beers on most weekdays and 4 or 5 beers on weekends but does not use illicit drugs.&nbsp; His vital signs, complete blood count, and comprehensive metabolic panel are within normal limits.&nbsp; Blood alcohol concentration is 0.005%.&nbsp; The patient&#39;s lacerations are sutured, and he is medically cleared.&nbsp; Mental status examination shows a thin, anxious man who is cooperative and oriented to person, place, and time.&nbsp; The patient makes poor eye contact and gives brief responses, repeatedly insisting, &#x22;Everything&#39;s fine, I&#39;m okay.&nbsp; I just want to go home.&#x22;&nbsp; He says he is not suicidal.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>Patients sometimes deny that they have made a <strong>suicide </strong><strong>attempt</strong>, due to either stigmatization or a desire to reattempt.&nbsp; The physician has a <strong>duty to assess</strong> the likelihood that an attempt has been made and the risk for further self-harm.&nbsp; Despite his denial, this patient has likely attempted suicide and is at high risk for a repeated attempt.&nbsp; He has numerous <strong>risk factors</strong> for suicide, including features suggestive of depression (weight loss, poor sleep, anxious affect), unemployment, living alone, risk of homelessness (eg, worried about paying rent), and active substance use, as well as a likely recent attempt.</p><p>Physicians should use their <strong>clinical judgment</strong> when assessing suicide risk and must always act to ensure <strong>patient safety</strong>.&nbsp; This patient should be <strong>hospitalized</strong> for his own protection, on <strong>involuntary status if necessary</strong>.&nbsp; It would be inappropriate and unsafe to manage his condition in an outpatient setting.</p><p><strong>(Choices A, B, and F)</strong>&nbsp; This patient should be hospitalized immediately for safety reasons.&nbsp; Although he may benefit from antidepressant therapy, psychotherapy, and social services, these interventions must initially take place in a supervised hospital setting due to his high suicide risk.</p><p><strong>(Choice D)</strong>&nbsp; Holding the patient for observation in the emergency department (ED) is indicated when factors are expected to resolve after a short period, making hospitalization unnecessary (eg, alcohol intoxication).&nbsp; This patient&#39;s blood alcohol concentration is negligible with no indication of an altered mental state.&nbsp; His suicide risk factors will not resolve in 24 hours without further intervention, and he should not be held in the ED unnecessarily, which would delay treatment.</p><p><strong>(Choice E)</strong>&nbsp; Although this patient&#39;s alcohol use should be addressed because it contributes to disinhibition and increases suicide risk, the priority is to ensure his safety.</p><p><strong>Educational objective:</strong><br>It is a physician&#39;s duty to use clinical judgment when assessing suicide risk.&nbsp; Even if a patient denies a suicide attempt, when a likely attempt has been made and the risk of further self-harm remains high, the patient must be hospitalized (involuntarily if necessary) to ensure safety.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 4449,
            "topic": "Suicide",
            "titleId": 4449,
            "title": "Suicide",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Arrange outpatient psychiatric follow-up for the following day",
                    "choiceNumber": 1,
                    "correctTaken": 471,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discuss options for antidepressant therapy and recommend outpatient psychotherapy",
                    "choiceNumber": 2,
                    "correctTaken": 446,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hospitalize the patient involuntarily",
                    "choiceNumber": 3,
                    "correctTaken": 12944,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observe the patient in the emergency department for 24 hours and then reassess",
                    "choiceNumber": 4,
                    "correctTaken": 2524,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform a brief intervention for alcohol use",
                    "choiceNumber": 5,
                    "correctTaken": 515,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer the patient to social services",
                    "choiceNumber": 6,
                    "correctTaken": 218,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22778709",
                    "mediaDataId": 0,
                    "title": "Civil commitment in the United States.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22778709",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 17118,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 559,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 14416,
            "questionIndex": 15825,
            "questionText": "<p>A 16-year-old girl is brought to the office by her mother due to concern about her behavior and grades.&nbsp; Her mother says, &#x22;She used to be a good student, but over the past few months, her grades have dropped, and she doesn&#39;t seem to care.&#x22;&nbsp; The patient has been in the annual school play since first grade but recently quit the drama club because &#x22;I am not into it anymore; I can&#39;t even remember the lines anyway.&#x22;&nbsp; She avoids her friends and spends a great deal of time in her room with the door locked.&nbsp; She goes to bed early, wakes up late, and takes naps of 1-2 hours when she gets home from school because she feels tired.&nbsp; Her mother reports that the patient has been more irritable, fighting frequently with her younger siblings.&nbsp; The patient responds, &#x22;I&#39;m the oldest and my brothers annoy me all the time.&nbsp; I just don&#39;t have any privacy at home!&#x22;&nbsp; She has no medical conditions and does not use tobacco, alcohol, or illicit drugs.&nbsp; Physical examination shows no abnormalities.&nbsp; The patient is cooperative but appears distracted at times and asks for several questions to be repeated.&nbsp; She appears fidgety and restless, frequently shifting in her seat and shaking her right leg.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42287\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\" style=\"width:75.0%;\"><p align=\"center\"><strong>Major depressive disorder</strong></p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width:75.0%;\"><ul><li>&ge;5 of the following symptoms lasting &ge;2 weeks (at least 1 symptom must be either depressed mood or loss of interest/pleasure):<ul style=\"list-style-type:circle;\"><li>Depressed mood</li><li>Loss of interest or pleasure</li><li>Change in appetite or weight</li><li>Insomnia or hypersomnia</li><li>Psychomotor retardation or agitation</li><li>Low energy</li><li>Poor concentration or indecisiveness</li><li>Thoughts of worthlessness or inappropriate guilt</li><li>Recurrent thoughts of death or suicide</li></ul></li><li>No history of mania or hypomania</li><li>Not due to substances or another medical condition</li></ul></td></tr></tbody></table></div><p>This patient has several findings suggestive of <strong>major depressive disorder</strong>, including the following:</p><ul><li>Loss of motivation and decreased interest (anhedonia) in school and activities she used to enjoy (eg, drama club, time with peers)</li><li>Sleep changes (eg, hypersomnia)</li><li>Lack of energy (eg, fatigue despite sleeping more)</li><li>Poor concentration (difficulty remembering lines, need for questions to be repeated)</li><li>Extreme irritability</li><li>Psychomotor agitation (fidgeting, restlessness)</li></ul><p>Like this patient, depressed <strong>adolescents</strong> may be <strong>irritable</strong> rather than sad.&nbsp; The degree of functional impairment at school and in relationships must be assessed in adolescents with suspected major depressive disorder.&nbsp; Although adolescents are frequently moody and desire privacy, this patient&#39;s behavior represents a <strong>marked change</strong> from her <strong>baseline</strong>.&nbsp; Her symptoms are causing significant <strong>academic dysfunction</strong> and <strong>social impairment</strong> inconsistent with normal adolescent behavior <strong>(Choice E)</strong>.</p><p>Other symptoms of major depressive disorder include changes in appetite or weight loss/gain, excessive guilt/feelings of worthlessness, and suicidal ideation.&nbsp; Treatment of adolescent depression consists of psychotherapy and, in severe cases, antidepressants (eg, fluoxetine).</p><p><strong>(Choice A)</strong>&nbsp; Although stressful life events often play a role in precipitating behavioral changes, adjustment disorder is not diagnosed if the symptoms are severe enough to meet the criteria for major depressive disorder.</p><p><strong>(Choice B)</strong>&nbsp; Attention deficit hyperactivity disorder has a chronic course and requires onset of symptoms prior to age 12.&nbsp; This patient&#39;s impaired concentration and fidgeting are symptoms of her depression.</p><p><strong>(Choice C)</strong>&nbsp; Disruptive mood dysregulation disorder is characterized by persistent irritability and frequent temper outbursts that begin prior to age 10; they are grossly out of proportion to the situation and inconsistent with developmental level.&nbsp; This disorder is not diagnosed when irritability and outbursts occur as part of a depressive episode.</p><p><strong>Educational objective:</strong><br>Adolescent depression may be characterized by irritability; loss of interest in previously enjoyed activities; fatigue; disturbances in sleep, concentration, and appetite; excessive guilt/feelings of worthlessness; and suicidal ideation.&nbsp; The severity of symptoms and related impairment can help differentiate depression from adjustment disorder and normal adolescent behavior.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 11037,
            "topic": "Child and adolescent mental health",
            "titleId": 11037,
            "title": "Child and adolescent mental health",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with mixed disturbance of emotions and conduct",
                    "choiceNumber": 1,
                    "correctTaken": 386,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Attention deficit hyperactivity disorder",
                    "choiceNumber": 2,
                    "correctTaken": 2156,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disruptive mood dysregulation disorder",
                    "choiceNumber": 3,
                    "correctTaken": 1050,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 10840,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal adolescent behavior",
                    "choiceNumber": 5,
                    "correctTaken": 2634,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "360,374,true,-1,1*946,1014,true,-1,1*1663,1779,true,-1,1*2012,2124,true,-1,1*2219,2558,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26325067",
                    "mediaDataId": 0,
                    "title": "Beyond a diagnosis: the experience of depression among clinically-referred adolescents.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26325067",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25524788",
                    "mediaDataId": 0,
                    "title": "Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25524788",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23771545",
                    "mediaDataId": 0,
                    "title": "Adolescent depression: clinical features and therapeutic strategies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23771545",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 222,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 17079,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 681,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 4881,
            "questionIndex": 4881,
            "questionText": "<p>A 28-year-old man comes to the office saying, &#x22;I&#39;m just not feeling like myself.&#x22;&nbsp; This change began soon after his older brother died of cancer 3 months ago.&nbsp; The patient feels sad and has lost interest in work and going out with friends on weekends.&nbsp; He falls asleep relatively easily at night but awakens very early in the morning and is unable to fall back asleep.&nbsp; The patient feels &#x22;very down,&#x22; especially when he first wakes up, but says that his mood improves a little during the day when he is busy.&nbsp; His poor energy and concentration have started to affect his performance at work, and he frequently thinks that, &#x22;I should just quit because I am bringing everyone down.&#x22;&nbsp; He has been eating less and has lost 5.4 kg (12 lb) over the past few weeks.&nbsp; The patient has had no suicidal thoughts.&nbsp; He has no psychiatric history other than counseling as a teenager when his parents divorced.&nbsp; The patient mentions that he had been close to his brother when they were growing up, but they drifted apart as adults.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33354\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Major depressive episode &amp; grief reaction</strong></p></td></tr><tr><td><p align=\"center\"><strong>Major depressive episode</strong></p></td><td><p align=\"center\"><strong>Grief reaction</strong></p></td></tr><tr><td style=\"width: 50%;\"><ul><li>&ge;2 weeks; &ge;5 of 9 symptoms:&nbsp;low mood, anhedonia, sleep disturbance, appetite change, low energy, psychomotor changes, guilt/worthlessness, concentration difficulty, suicidal ideation</li><li>May occur in response to a variety of stressors, including loss of a loved one</li><li>Marked social &amp; occupational dysfunction</li><li>Suicidality related to hopelessness &amp; worthlessness</li></ul></td><td style=\"width: 50%; vertical-align: top;\"><ul><li>Normal reaction to loss (bereavement)</li><li>Sadness more specific to thoughts of the deceased&nbsp;</li><li>&quot;Waves&quot; of grief at reminders</li><li>Self-esteem usually preserved</li><li>Functional decline less severe</li><li>Thoughts of dying involve wish to join the deceased; active suicidality uncommon</li><li>Intensity decreases over time</li></ul></td></tr></tbody></table></div><p>Although this patient&#39;s depressive symptoms developed in response to the stressor of bereavement, his symptoms are sufficient in number, duration, and severity to meet diagnostic criteria for a <strong>major depressive episode</strong> (ie, depressed mood, loss of interest, early morning awakening, weight loss, low energy, impaired concentration lasting &#8805;2 weeks).&nbsp; Patients with &#8805;1 major depressive episode and no history of mania or hypomania are diagnosed with <strong>major depressive disorder (MDD)</strong>.&nbsp; DSM-5 allows for the diagnosis of MDD during the bereavement period because evidence has shown that <strong>bereavement-related major depression</strong> and major depression not related to bereavement have a <strong>similar course</strong> and <strong>response</strong> to <strong>treatment</strong>.&nbsp; The death of a loved one is similar to any other serious stressor that can trigger a major depressive episode.</p><p>Major depression can be difficult to differentiate from acute grief.&nbsp; In a normal grief reaction, sadness is typically focused on the deceased and decreases in intensity over several weeks, with intermittent waves of grief mixed with positive memories <strong>(Choice D)</strong>.&nbsp; A major depressive episode involves more persistent sadness and pervasive anhedonia (as in this patient).&nbsp; Excessive guilt, self-critical ruminations, and suicidality related to feelings of worthlessness and hopelessness can also help distinguish MDD from normal grief.</p><p><strong>(Choice A)</strong>&nbsp; Acute stress disorder develops within one month of a traumatic event and is characterized by intrusive re-experiencing (eg, flashbacks, intense memories), negative mood and cognitions, avoidance, and hyperarousal.</p><p><strong>(Choice B)</strong>&nbsp; Adjustment disorder with depressed mood is characterized by depressive symptoms that develop in response to a stressor.&nbsp; However, symptoms should not represent normal bereavement and cannot be diagnosed when criteria are met for another disorder, such as MDD in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Persistent complex bereavement disorder (also called complicated grief) is characterized by persistent yearning for the deceased and prolonged emotional pain related to the loss.&nbsp; It is accompanied by maladaptive, ruminative thoughts and dysfunctional behaviors.&nbsp; This patient&#39;s depression does not revolve around yearning for his brother.</p><p><strong>Educational objective:</strong><br>Major depressive disorder can be diagnosed if depressive symptoms following the loss of a loved one are sufficiently severe to meet diagnostic criteria.&nbsp; Compared to normal grief, major depression is associated with more persistent and pervasive sadness, feelings of hopelessness and worthlessness, and suicidal ideation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute stress disorder",
                    "choiceNumber": 1,
                    "correctTaken": 76,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with depressed mood",
                    "choiceNumber": 2,
                    "correctTaken": 2226,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 3,
                    "correctTaken": 11833,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal grief reaction",
                    "choiceNumber": 4,
                    "correctTaken": 2371,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent complex bereavement disorder",
                    "choiceNumber": 5,
                    "correctTaken": 567,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "295,373,true,-1,1*505,555,true,-1,1*647,727,true,-1,1*2288,2318,true,-1,1*2648,2987,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24136623",
                    "mediaDataId": 0,
                    "title": "The removal of the bereavement exclusion in the DSM-5: exploring the evidence.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24136623",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24068457",
                    "mediaDataId": 0,
                    "title": "Bereavement and complicated grief.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24068457",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24042244",
                    "mediaDataId": 0,
                    "title": "Grief, depression, and the DSM-5.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24042244",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 17073,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 853,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 14432,
            "questionIndex": 15841,
            "questionText": "<p>A 35-year-old man with a history of bipolar disorder since age 27 comes to the office for follow-up.&nbsp; The patient was hospitalized 2 years ago for a manic episode and was discharged with a therapeutic dose of lithium; he continues to take the same dose and is engaged in weekly psychotherapy.&nbsp; The patient says, &#x22;This is the best I&#39;ve felt in years; work is going great, and I&#39;m getting married in a few months.&nbsp; I really don&#39;t want to get hospitalized again, but I also don&#39;t want to keep taking medication if I don&#39;t have to.&#x22;&nbsp; Prior medication trials include quetiapine and olanzapine with fluoxetine; both treatments were discontinued due to weight gain.&nbsp; Medical history is noncontributory.&nbsp; Vital signs and physical examination are unremarkable.&nbsp; The patient appears euthymic and has a full range of affect.&nbsp; Complete blood count, basic metabolic panel, and TSH are within normal limits; serum lithium level is within therapeutic range.&nbsp; Which of the following is the most appropriate response to this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Bipolar disorder</strong> is a highly recurrent illness, and multiple mood episodes are typical.&nbsp; The goal of <strong>maintenance treatment</strong> is to decrease the risk for recurrent manic and depressive episodes that can severely impair functioning and relationships.&nbsp; <strong>Lithium </strong>is a first-line agent that has been studied extensively and helps decrease rates of relapse in patients with bipolar disorder.&nbsp; Discontinuing stable lithium treatment usually leads to a recurrent episode within months to a year and carries risks of hospitalization, economic losses, and suicide.</p><p>Understanding the patient&#39;s reasons for not wanting to be on medication and responding to any specific concerns he has about lithium are important.&nbsp; However, treatment recommendations must take into account the <strong>high risk of recurrent episodes</strong>.&nbsp; This patient is doing well on a therapeutic dose of lithium (ie, no recurrent manic or depressive episodes since starting lithium 2 years ago) and is tolerating the medication without difficulty.&nbsp; His medication history indicates that other treatment options (ie, quetiapine, olanzapine with fluoxetine) resulted in unacceptable weight gain.&nbsp; The most appropriate response is to recommend <strong>continuing lithium at the same dose</strong> while monitoring for side effects.&nbsp; An analogy can be made to other chronic illnesses (eg, asthma) that may require prolonged medication usage.</p><p><strong>(Choice A)</strong>&nbsp; Because bipolar disorder is a highly recurrent illness, tapering off medication is not recommended.</p><p><strong>(Choice C)</strong>&nbsp; Lowering the dose of lithium is sometimes done to manage side effects.&nbsp; This patient&#39;s lithium dose is in the therapeutic range, and he is tolerating the medication without adverse effects;&nbsp;lowering the dose may result in a subtherapeutic dose and increase his risk for recurrence.</p><p><strong>(Choice D)</strong>&nbsp; Long-acting injectable antipsychotic agents (eg haloperidol, aripiprazole, risperidone) can be considered for maintenance treatment in bipolar disorder and can be especially useful for improving adherence.&nbsp; However, they are third-line agents typically used in patients who tolerated oral formulations.&nbsp; This patient is doing well on lithium, with a therapeutic blood level indicating adherence.&nbsp; Changing to a long-acting injectable is not indicated and may result in destabilization (eg, lag before reaching therapeutic levels) or be associated with side effects.</p><p><strong>Educational objective:</strong><br>Bipolar disorder is a highly recurrent illness.&nbsp; Maintenance treatment is recommended to decrease the risk of recurrent manic or depressive episodes.&nbsp; Lithium therapy should be maintained in patients whose condition is stable and who are tolerating the medication.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Mood episodes are often triggered by stress or change; let&#39;s continue the medication for now and begin tapering it after your wedding.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 1871,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Mood episodes in bipolar disorder are highly recurrent; I suggest continuing lithium at the current dose and monitoring for side effects.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 10928,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Since you have had no mood episodes in the past 2 years and you meet regularly for therapy, it would be reasonable to decrease your dose.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 1682,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;We can try switching to a medication that you don&#39;t have to take daily; let&#39;s talk about the available long-acting injectable treatments.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 2503,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "276,580,true,-1,1*1814,1902,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "102",
                    "mediaDataId": 0,
                    "title": "Bipolar I disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26360999",
                    "mediaDataId": 0,
                    "title": "Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26360999",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27287789",
                    "mediaDataId": 0,
                    "title": "Long term use of lithium and factors associated with treatment response among patients with bipolar disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27287789",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31026388",
                    "mediaDataId": 0,
                    "title": "Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31026388",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 82,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16984,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 520,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 11129,
            "questionIndex": 12275,
            "questionText": "<p>A 52-year-old man comes to the office due to low energy and poor sleep.&nbsp; The patient reports feeling stressed since his divorce last year.&nbsp; He has difficulty sleeping through the night and awakens around 4:00 AM most mornings, earlier than he would like.&nbsp; At work, the patient is unable to concentrate and has become less productive.&nbsp; Although he loves his children, he no longer enjoys visiting them on the weekends and makes excuses to stay home.&nbsp; The patient says that food is tasteless, and his appetite has decreased significantly over the past 2 months.&nbsp; Blood pressure is 136/84 mm Hg and pulse is 78/min.&nbsp; Physical examination is normal.&nbsp; Mental status examination shows a depressed and anxious mood, with mild psychomotor agitation.&nbsp; He has no psychotic features or suicidal ideation.&nbsp; This patient is most likely to have which of the following abnormalities?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient meets the criteria for <strong>major depressive disorder</strong> with his evident depressed mood, anhedonia, decreased appetite, early-morning awakening insomnia, low energy, impaired concentration, and psychomotor agitation.&nbsp; <strong>Hyperactivity</strong> of the <strong>hypothalamic-pituitary-adrenal axis</strong>, resulting in <strong>increased cortisol levels</strong> (without signs/symptoms of Cushing syndrome), has been associated with depression.</p><p>The neurocytotoxic effects of hypercortisolemia may play an important role in the pathogenesis of depressive symptoms and associated cognitive deficits.&nbsp; These effects may also explain the association of stress and trauma with the increased risk for development of depression.&nbsp; Other findings in patients with depression include glucocorticoid-mediated decreased hippocampal volume and suppressed neural connection.</p><p>Effective psychotherapy for depression (ie, cognitive-behavioral therapy, interpersonal therapy) incorporates stress reduction into treatment, whereas antidepressant pharmacotherapy promotes neural plasticity to restore damaged pathways.&nbsp; It is suspected that the improved intrapersonal and interpersonal functioning and enhanced social support from therapy influence and augment the antidepressant-mediated plasticity.</p><p><strong>(Choice A)</strong>&nbsp; Although hippocampal atrophy can be seen in depression, enlarged lateral cerebral ventricles are more commonly associated with schizophrenia.</p><p><strong>(Choices B and E)</strong>&nbsp; REM sleep latency (ie, time from sleep onset until the start of the first REM sleep period) is decreased, not increased, in depression.&nbsp; In addition, slow-wave sleep (ie, deep sleep) is decreased, not increased, in depression.</p><p><strong>(Choice C)</strong>&nbsp; Lactate infusion can provoke panic attacks in susceptible patients and has been used in research to identify those with panic disorder.</p><p><strong>Educational objective:</strong><br>Major depressive disorder is associated with hyperactivity of the hypothalamic-pituitary-adrenal axis, resulting in increased cortisol levels.&nbsp; Antidepressants and psychotherapy may restore the emotional processing pathways damaged by cortisol.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Enlarged lateral cerebral ventricles",
                    "choiceNumber": 1,
                    "correctTaken": 92,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased REM sleep latency",
                    "choiceNumber": 2,
                    "correctTaken": 1928,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased sensitivity to lactate infusion",
                    "choiceNumber": 3,
                    "correctTaken": 168,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased serum cortisol concentration",
                    "choiceNumber": 4,
                    "correctTaken": 2177,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased slow-wave sleep",
                    "choiceNumber": 5,
                    "correctTaken": 653,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1680,1817,true,-1,1*1282,1423,true,-1,1*1443,1669,true,-1,1*711,849,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26412074",
                    "mediaDataId": 0,
                    "title": "The neurobiological mechanisms and treatments of REM sleep disturbances in depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26412074",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25999722",
                    "mediaDataId": 0,
                    "title": "The cortisol awakening response and major depression: examining the evidence.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25999722",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 124,
            "othersAvgTimeSpent": 71,
            "notes": null,
            "peopleTaken": 5018,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1443,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 2351,
            "questionIndex": 2351,
            "questionText": "<p>A 59-year-old man comes to the office due to worsening depression and insomnia since his wife died 7 months ago from cancer.&nbsp; The patient is frequently tearful and is no longer interested in socializing with his married friends.&nbsp; He has attended 3 sessions of supportive psychotherapy and expresses appreciation for the referral because he likes the therapist.&nbsp; However, he continues to feel depressed and is now experiencing severe insomnia.&nbsp; The patient has difficulty falling and staying asleep, frequently lying awake at night thinking about his wife.&nbsp; He feels very guilty about her death and believes that he should have done more for her during her final months.&nbsp; His appetite is poor and he says it is easier to buy prepared foods than cook for himself.&nbsp; Last week, the patient experienced a moment of severe depression in which he briefly thought that he would be better off dead.&nbsp; However, he insists that he would never act on these thoughts.&nbsp; Vital signs are normal.&nbsp; Physical examination is unremarkable aside from a 3.6-kg (8-lb) weight loss since his wife&#39;s death.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>Although there is considerable symptom overlap between <a href=\"874\">grief reactions and major depression</a>, this patient&#39;s worsening depression is concerning.&nbsp; His symptoms meet the criteria for a <strong>major depressive episode</strong> and include depressed mood, loss of interest, insomnia, guilt, low energy, weight loss, and thoughts of death.&nbsp; A major depressive episode is <strong>diagnosed regardless of an existing precipitant</strong>, including bereavement.</p><p>Appropriate first-line treatment of major depression includes <strong>antidepressant medication</strong> and <strong>psychotherapy</strong>.&nbsp; Although selective serotonin reuptake inhibitors are commonly used as a first choice for the treatment of depressive disorders, <strong>mirtazapine</strong> would be a preferred choice for this patient with poor sleep and appetite.&nbsp; Mirtazapine is a first-line antidepressant medication whose side effects include stimulation of appetite, weight gain, and somnolence.</p><p><strong>(Choices A, B, and G)</strong>&nbsp; This patient&#39;s symptoms are more severe and persistent than would be expected in a normal grief reaction.&nbsp; Although he appears to have a good relationship with his therapist, his depression is worsening.&nbsp; Educating the patient about grief, continuing/increasing the frequency of psychotherapy, or adding a grief support group would not adequately address his worsening depressive symptoms (ie, weight loss, marked insomnia, passive suicidal ideation).</p><p><strong>(Choice C)</strong>&nbsp; Tricyclic antidepressants (eg, amitriptyline) are not considered first-line treatment due to significant anticholinergic side effects, orthostatic hypotension, and cardiotoxicity in overdose.</p><p><strong>(Choice E)</strong>&nbsp; Zolpidem is a non-benzodiazepine sleep medication that would not adequately treat this patient&#39;s underlying depression.</p><p><strong>(Choice F)</strong>&nbsp; Electroconvulsive therapy is used mainly for patients who do not respond to antidepressants and for severely depressed patients who are catatonic, psychotic, acutely suicidal, or not eating or drinking.&nbsp; This patient&#39;s condition is less severe and would benefit from initial antidepressant treatment.</p><p><strong>Educational objective:</strong><br>Bereaved patients who develop moderate to severe major depression should be considered for treatment with both psychotherapy and antidepressants.&nbsp; Mirtazapine is a preferred choice for patients with marked insomnia and weight loss due to its side effects of appetite stimulation and sedation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Educate the patient regarding the course of grief and continue psychotherapy",
                    "choiceNumber": 1,
                    "correctTaken": 910,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase the frequency of psychotherapy sessions to twice weekly",
                    "choiceNumber": 2,
                    "correctTaken": 266,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe amitriptyline and continue psychotherapy",
                    "choiceNumber": 3,
                    "correctTaken": 1280,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe mirtazapine and continue psychotherapy",
                    "choiceNumber": 4,
                    "correctTaken": 10572,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe zolpidem for insomnia and continue psychotherapy",
                    "choiceNumber": 5,
                    "correctTaken": 1347,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend electroconvulsive therapy",
                    "choiceNumber": 6,
                    "correctTaken": 1193,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer to a grief support group and continue psychotherapy",
                    "choiceNumber": 7,
                    "correctTaken": 1351,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1731,2032,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26474367",
                    "mediaDataId": 0,
                    "title": "Symptom and functional traits of brief major depressive episodes and discrimination of bereavement.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26474367",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21644844",
                    "mediaDataId": 0,
                    "title": "Review of the use of mirtazapine in the treatment of depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21644844",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 164,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 16919,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 723,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 11391,
            "questionIndex": 12547,
            "questionText": "<p>A 15-year-old boy is brought to the office by his parents due to concern about a change in his behavior.&nbsp; Over the past 3 months he has become more withdrawn, spending more time alone and turning down opportunities to socialize with his friends.&nbsp; He is frequently moody and irritable.&nbsp; The patient feels unmotivated at school and seems unconcerned that his grades have dropped.&nbsp; His parents believe that his behavior changed after he was rejected by a girl, who subsequently called him a &#x22;loser&#x22; on social media.&nbsp; When seen alone, the patient says, &#x22;I don&#39;t think I will ever get over this girl,&#x22; who he believes was his &#x22;soul mate.&#x22;&nbsp; He uses marijuana occasionally but does not use alcohol.&nbsp; Physical examination is normal apart from a 2.7-kg (6-lb) weight loss since his last visit.&nbsp; He says, &#x22;I feel pretty down.&nbsp; I would consider talking to someone or taking medication but don&#39;t want to worry my parents.&#x22;&nbsp; Which of the following is the most appropriate step prior to initiating treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient shows signs and symptoms concerning for <strong>depression</strong> (eg, social isolation, lack of motivation, irritable mood, academic decline, weight loss).&nbsp; Before initiating treatment, a <strong>suicide-risk assessment</strong> must be performed because it could have immediate implications for safety and for determining the appropriate treatment setting.&nbsp; The physician should ask <strong>specific questions</strong> in a <strong>direct</strong> and <strong>nonjudgmental</strong> manner.&nbsp; These include: Do you wish you were dead?&nbsp; Are you having thoughts about harming or killing yourself?&nbsp; Have you made any plans or preparations to kill yourself?&nbsp; Have you ever tried to kill yourself?</p><p>Suicide is a leading cause of death in adolescents.&nbsp; The combination of depression (particularly in the setting of rejection and humiliation/cyberbullying) and impulsivity (which is characteristic of adolescence) places this patient at increased risk and should not be underestimated.&nbsp; <strong>Confidentiality</strong> should <strong>not</strong> be <strong>promised</strong> because it cannot be maintained if there is a concern for safety <strong>(Choice A)</strong>.&nbsp; Depending on the assessment, this patient may require immediate psychiatric evaluation in the emergency department and/or hospitalization.</p><p><strong>(Choices B, D, and G)</strong>&nbsp; Although parental consent is required to prescribe medication, and it is important to respond to this patient&#39;s interest in treatment, it is premature to recommend treatment with antidepressants and/or psychotherapy prior to completing a thorough assessment.</p><p><strong>(Choice C)</strong>&nbsp; Although adolescents should be encouraged to involve their parents in decision-making, the priority in this case is to determine if the patient is a danger to himself.&nbsp; If there is any concern for the patient&#39;s safety, the parents must be informed with or without consent.</p><p><strong>(Choice F)</strong>&nbsp; This patient has had persistent depressive symptoms for 3 months and should not simply be reassured.&nbsp; A thorough evaluation for depression, including careful screening for suicidal thoughts, is necessary.</p><p><strong>Educational objective:</strong><br>Suicide-risk assessment in adolescents should include direct and nonjudgmental questions to determine the nature and intensity of suicidal thoughts.&nbsp; Confidentiality should not be promised because it cannot be maintained if the patient is at high risk for self-harm.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 11037,
            "topic": "Child and adolescent mental health",
            "titleId": 11037,
            "title": "Child and adolescent mental health",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Assure the patient that everything he says is confidential",
                    "choiceNumber": 1,
                    "correctTaken": 2678,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discuss the risks and benefits of psychotherapy versus medication",
                    "choiceNumber": 2,
                    "correctTaken": 270,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Encourage the patient to tell his parents how he feels",
                    "choiceNumber": 3,
                    "correctTaken": 877,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inform the patient that parental permission is needed to prescribe medication",
                    "choiceNumber": 4,
                    "correctTaken": 231,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inquire if the patient has thoughts of harming himself",
                    "choiceNumber": 5,
                    "correctTaken": 15820,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassure the patient that sadness is normal after a romantic breakup",
                    "choiceNumber": 6,
                    "correctTaken": 276,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend psychotherapy in addition to medication",
                    "choiceNumber": 7,
                    "correctTaken": 133,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "453,653,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25124208",
                    "mediaDataId": 0,
                    "title": "Mood disorders in adolescents: diagnosis, treatment, and suicide assessment in the primary care setting.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25124208",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24897985",
                    "mediaDataId": 0,
                    "title": "Risk assessment and initial management of suicidal adolescents.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24897985",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 116,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 20285,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 403,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 14402,
            "questionIndex": 15811,
            "questionText": "<p>A 72-year-old woman comes to the emergency department accompanied by her son due to worsening depression for the past few weeks.&nbsp; She has recurrent major depressive disorder and a prior suicide attempt.&nbsp; The patient was taking venlafaxine with good response until a month ago, when she discontinued it because she felt it was &#x22;unnecessary.&#x22;&nbsp; Her son, whom she lives with, noticed that she has become more withdrawn, staying in her bedroom and preferring to sit in the dark watching television instead of sleeping.&nbsp; The patient has been refusing meals to &#x22;sacrifice&#x22; herself for &#x22;the greater good&#x22; and repeatedly tells her son that she &#x22;must die in accordance with the divine plan.&#x22;&nbsp; Height is 165 cm (5 ft 5 in), and weight is 49 kg (108 lb).&nbsp; BMI is 18 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows decreased skin turgor and dry mucous membranes.&nbsp; On mental status examination, her clothes are stained and malodorous.&nbsp; The patient makes minimal eye contact and looks at the floor for most of the evaluation.&nbsp; She does not respond to most questions, although she correctly states her name, birthdate, and today&#39;s date.&nbsp; Which of the following is the most appropriate treatment for this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T34512\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Electroconvulsive therapy for depression</strong></p></td></tr><tr><td><p align=\"center\"><strong>Indications</strong></p></td><td><ul><li>Treatment resistance</li><li>Psychotic features</li><li>Emergency conditions<ul style=\"list-style-type:circle;\"><li>Pregnancy</li><li>Refusal to eat or drink</li><li>Imminent risk for suicide</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Safety</strong></p></td><td><ul><li>No absolute contraindications</li><li>Increased risk&nbsp;<ul style=\"list-style-type:circle;\"><li>Severe cardiovascular disease,<br>recent myocardial infarction</li><li>Space-occupying brain lesion</li><li>Recent stroke, unstable aneurysm</li></ul></li></ul></td></tr></tbody></table></div><p>This patient&#39;s worsening depressive symptoms, extreme functional decline, and meal refusal to &#x22;sacrifice&#x22; herself for &#x22;the greater good&#x22; while insisting that she &#x22;must die in accordance with the divine plan&#x22; is consistent with <strong>major depressive disorder</strong> (MDD) <strong>with psychotic features</strong>.&nbsp; Psychotic features may be subtle or intermittent but often include delusions and/or hallucinations with depressive themes of deserved punishment, guilt, worthlessness, and/or catastrophe.</p><p>First-line treatment of psychotic depression consists of either an antidepressant plus an antipsychotic or <strong>electroconvulsive therapy</strong> (ECT) alone.&nbsp; However, MDD with psychotic features progresses to a <strong>suicide attempt in up to 25%</strong> of patients.&nbsp; Therefore, when suicidality presents in this population, it should be treated aggressively; <strong>ECT</strong> can provide a <strong>rapid reduction in symptoms</strong>.</p><p>In this scenario, the patient&#39;s psychotic depression with suicidal motivation to her meal restriction resulted in physical manifestations of <strong>dehydration</strong> (eg, decreased skin turgor, dry mucous membranes), with likely significant weight loss.&nbsp; She should be offered inpatient psychiatric treatment so ECT can be pursued.&nbsp; ECT is a safe and effective procedure and has no absolute contraindications.&nbsp; It is typically administered 3 times a week for a course of 6-12 treatments.</p><p><strong>(Choices A and D)</strong>&nbsp; Clozapine is an antipsychotic primarily reserved for use in treatment-resistant schizophrenia due to the risk for agranulocytosis.&nbsp; Olanzapine is an effective antipsychotic that can stimulate appetite to increase oral intake.&nbsp; However, antipsychotic monotherapy is insufficient.&nbsp; An antidepressant plus an antipsychotic is necessary to treat MDD with psychotic features.</p><p><strong>(Choices C, E, and F)</strong>&nbsp; Mirtazapine is an antidepressant that can stimulate appetite to increase oral intake.&nbsp; Venlafaxine is a serotonin norepinephrine reuptake inhibitor, and sertraline is a selective serotonin reuptake inhibitor that can be augmented with the dopamine norepinephrine reuptake inhibitor bupropion.&nbsp; These antidepressants are indicated in the treatment of MDD.&nbsp; However, antidepressant therapy alone is insufficient for MDD with psychotic features, and the prolonged time to effectiveness makes ECT a better option.</p><p><strong>Educational objective:</strong><br>Electroconvulsive therapy is a safe and effective first-line treatment for major depressive disorder with psychotic features.&nbsp; It is particularly appropriate for severely depressed patients who refuse to eat and drink or are acutely suicidal.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Clozapine",
                    "choiceNumber": 1,
                    "correctTaken": 600,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Electroconvulsive therapy",
                    "choiceNumber": 2,
                    "correctTaken": 6712,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mirtazapine",
                    "choiceNumber": 3,
                    "correctTaken": 770,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Olanzapine",
                    "choiceNumber": 4,
                    "correctTaken": 1996,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline and bupropion",
                    "choiceNumber": 5,
                    "correctTaken": 671,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Venlafaxine",
                    "choiceNumber": 6,
                    "correctTaken": 1305,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1632,1708,true,-1,1*83,103,true,-1,1*144,153,true,-1,1*317,345,true,-1,1*361,378,true,-1,1*664,851,true,-1,1*852,996,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "101",
                    "mediaDataId": 0,
                    "title": "Major depressive disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28406327",
                    "mediaDataId": 0,
                    "title": "Key updates in the clinical application of electroconvulsive therapy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28406327",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25995098",
                    "mediaDataId": 0,
                    "title": "Neuromodulation therapies for geriatric depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25995098",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 112,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 12054,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1073,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 4883,
            "questionIndex": 4883,
            "questionText": "<p>A 46-year-old man with a history of medication-controlled hypertension comes to the office for a routine checkup.&nbsp; Blood pressure is 115/80 mm Hg and physical examination findings are normal.&nbsp; The physician notes that the patient&#39;s mood seems low.&nbsp; The patient admits that he has been &#x22;stressed out&#x22; for the past 2 months as a few people at work recently quit and he has had to take on more responsibility while management finds replacements.&nbsp; He has not been able to exercise or eat right as he is so busy.&nbsp; The patient feels irritable and tense at work and has had neck and shoulder pain.&nbsp; He is also worried about not being able to spend time with his wife, who complains that he works too much.&nbsp; The patient has occasional difficulty falling asleep at night after working long hours and feels tired during the day.&nbsp; Although he doesn&#39;t enjoy his job, he has no choice but to stay.&nbsp; He continues to get his work done and enjoys social activities, including playing golf on weekends.&nbsp; The patient drinks 2-3 cans of beer on weekends and smokes marijuana twice a month.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33834\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Differential diagnosis of depressed mood </strong></p></td></tr><tr><td><p align=\"center\"><strong>Major depressive disorder </strong></p></td><td><ul><li>&ge;2 weeks</li><li><strong>&ge;5 of 9 </strong>symptoms: depressed mood &amp; SIGECAPS</li><li>Significant functional impairment</li><li>No lifetime history of mania</li></ul></td></tr><tr><td><p align=\"center\"><strong>Persistent depressive disorder (dysthymia) </strong></p></td><td><ul><li>Chronic depressed mood &ge;2 years</li><li>&ge;2 of the following: appetite disturbance, sleep disturbance, low energy, low self-esteem, poor concentration, hopelessness</li></ul></td></tr><tr><td><p align=\"center\"><strong>Adjustment disorder with depressed mood </strong></p></td><td><ul><li>Onset within 3 months of identifiable stressor</li><li>Marked distress &amp;/or functional impairment</li><li>Does not meet criteria for another DSM-5-TR&nbsp;disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Normal stress response </strong></p></td><td><ul><li>Not excessive or out of proportion to severity of stressor</li><li>No significant functional impairment</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SIGECAPS</strong> = <strong>S</strong>leep disturbance, loss of <strong>I</strong>nterest, excessive <strong>G</strong>uilt, low <strong>E</strong>nergy, impaired <strong>C</strong>oncentration, <strong>A</strong>ppetite disturbance, <strong>P</strong>sychomotor agitation/retardation, and <strong>S</strong>uicidal ideation.&nbsp;</p></td></tr></tbody></table></div><p>This patient&#39;s symptoms in response to his stressful work situation (eg, mood appears low, poor sleep, fatigue) are consistent with a <strong>normal stress response</strong>.&nbsp; His symptoms are mild rather than excessive given the nature of the stressor; he does not meet the full criteria for any disorder; and he is not markedly distressed (eg, does not himself bring the subject up with the physician).&nbsp; Most importantly, the patient exhibits <strong>no impairment of social and occupational functioning</strong>, a key feature of psychiatric illness.&nbsp; This patient continues to function well (eg, still performs at work, enjoys socializing and leisure activities).</p><p><strong>(Choice A)</strong>&nbsp; Acute stress disorder is characterized by symptoms of reexperiencing (intrusive memories and flashbacks), avoidance, negative mood, dissociation, and hyperarousal lasting from 3 days to 1 month following a traumatic event.</p><p><strong>(Choice B)</strong>&nbsp; In adjustment disorder with depressed mood, depressive symptoms develop within 3 months of the onset of an identifiable stressor.&nbsp; In contrast to a normal stress response, it involves marked distress out of proportion to the stressor and/or impaired social or occupational functioning.</p><p><strong>(Choice C)</strong>&nbsp; Irritability, tension, and poor sleep can be seen in generalized anxiety disorder; however, this diagnosis requires excessive worries about multiple issues and duration of &#8805;6 months.</p><p><strong>(Choice D)</strong>&nbsp; Diagnostic criteria for major depressive disorder include a 2-week period of at least 5 of 9 symptoms:&nbsp; Depressed mood + <strong>S</strong>leep disturbance, loss of <strong>I</strong>nterest, excessive <strong>G</strong>uilt, low <strong>E</strong>nergy, impaired <strong>C</strong>oncentration, loss of <strong>A</strong>ppetite, <strong>P</strong>sychomotor agitation/retardation, and <strong>S</strong>uicidal ideation (SIGECAPS mnemonic).&nbsp; This diagnosis requires significant functional impairment and may be given regardless of an identifiable precipitant.</p><p><strong>(Choice F)</strong>&nbsp; Although medication- or substance-induced depressive symptoms should be ruled out, there is no evidence to suggest that this patient&#39;s medication or substance use is causing his symptoms, which seem etiologically connected to his work situation.&nbsp; Antihypertensives seldom cause depression.</p><p><strong>Educational objective:</strong><br>Patients with situationally triggered depressive symptoms should be assessed for major depressive and adjustment disorders.&nbsp; Normal stress reactions are distinguished by lower severity and absence of marked distress or significant functional impairment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 396,
            "topic": "Adjustment disorders",
            "titleId": 396,
            "title": "Adjustment disorders",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute stress disorder",
                    "choiceNumber": 1,
                    "correctTaken": 1233,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with depressed mood",
                    "choiceNumber": 2,
                    "correctTaken": 5095,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 844,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 534,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal stress response",
                    "choiceNumber": 5,
                    "correctTaken": 12682,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Substance/medication-induced depressive disorder",
                    "choiceNumber": 6,
                    "correctTaken": 84,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1913,2067,true,-1,1*1289,1534,true,-1,1*291,414,true,-1,1*503,545,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26468001",
                    "mediaDataId": 0,
                    "title": "To Be or Not to Be (Stressed):  the Critical Role of a Psychologically Healthy Workplace in Effective Stress Management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26468001",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24246431",
                    "mediaDataId": 0,
                    "title": "Overdiagnosis problems in the DSM-IV and the new DSM-5:  can they be resolved by the distress-impairment criterion?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24246431",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 136,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 20473,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 670,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 14414,
            "questionIndex": 15823,
            "questionText": "<p>A 38-year-old woman comes to the office for follow-up of major depressive disorder.&nbsp; She was first seen 2 weeks ago for low mood and irritability, loss of interest, difficulty falling and staying asleep, decreased appetite, and poor concentration at work.&nbsp; At that time, she was started on a therapeutic dosage of escitalopram and weekly psychotherapy.&nbsp; The patient had mild nausea for several days after starting the medication but is now tolerating it without difficulty.&nbsp; She says, &#x22;I&#39;m afraid the medication isn&#39;t working as well anymore.&nbsp; At first my sleep and appetite were better, but for the past few days I feel like I might be slipping back to where I started.&#x22;&nbsp; The patient reports that she is stressed because her husband is away on business this week and her father was recently hospitalized for a stroke.&nbsp; Mental status examination shows a mildly depressed mood and sad affect.&nbsp; Which of the following is the most appropriate next step in pharmacological management?</p>",
            "questionHeader": "",
            "explanationText": "<p>Assessment of antidepressant medication response requires that the patient has had an adequate trial in both dose and duration.&nbsp; An <strong>adequate antidepressant trial</strong> is generally considered to be at least <strong>4-6 weeks at a therapeutic dosage</strong>.&nbsp; This patient has taken escitalopram for only 2 weeks, which is considered an inadequate trial in duration.&nbsp; Her lack of sustained improvement after 2 weeks is not uncommon, and her symptoms over the past week are likely related in part to psychosocial stress (father hospitalized, husband away).</p><p>The most appropriate step in pharmacotherapy is to continue the trial of escitalopram at the current dosage.&nbsp; Increasing the dosage is unnecessary and risks exposing the patient to additional side effects <strong>(Choice E)</strong>.&nbsp; The patient should be educated that 2 weeks is considered an inadequate trial and encouraged to continue the medication for at least 2-4 more weeks.&nbsp; Patients should receive an adequate antidepressant trial before next-step treatments are recommended, such as augmentation with a second medication or switching to an alternate antidepressant.</p><p><strong>(Choices A and B)</strong>&nbsp; It would be premature to add amitriptyline at bedtime or aripiprazole after only 2 weeks of escitalopram.&nbsp; These augmentation strategies could be considered in a patient who has failed an adequate trial of monotherapy.</p><p><strong>(Choices C and D)</strong>&nbsp; Discontinuing antidepressant medication at the 2-week point would be premature.&nbsp; Switching to an alternate antidepressant can be considered for patients with minimal response after an adequate trial of 4-6 weeks or for those unable to tolerate the medication.&nbsp; Trazodone is a very sedating medication that is often difficult to tolerate in dosages required to treat depression.</p><p><strong>Educational objective:</strong><br>An antidepressant trial is at least 4-6 weeks at a therapeutic dose.&nbsp; Physicians should continue antidepressants for at least 4-6 weeks before considering the next step in treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 15808,
            "topic": "Antidepressants",
            "titleId": 15808,
            "title": "Antidepressants",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add amitriptyline at bedtime",
                    "choiceNumber": 1,
                    "correctTaken": 124,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Add aripiprazole",
                    "choiceNumber": 2,
                    "correctTaken": 119,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue escitalopram and start paroxetine",
                    "choiceNumber": 3,
                    "correctTaken": 229,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue escitalopram and start trazodone",
                    "choiceNumber": 4,
                    "correctTaken": 136,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase dose of escitalopram",
                    "choiceNumber": 5,
                    "correctTaken": 3757,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maintain current dose of escitalopram",
                    "choiceNumber": 6,
                    "correctTaken": 12606,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1642,1758,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "101",
                    "mediaDataId": 0,
                    "title": "Major depressive disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26935957",
                    "mediaDataId": 0,
                    "title": "Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26935957",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 106,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 16971,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 471,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 14495,
            "questionIndex": 15904,
            "questionText": "<p>A 42-year-old man comes to the office due to persistent sadness, weight gain, and fatigue over the past 4 months.&nbsp; The patient is a dentist who has had difficulty waking up in the morning for clinic.&nbsp; He says, &#x22;I used to be really efficient, but now I always run 2 hours behind schedule.&#x22;&nbsp; He has been eating &#x22;lots of fast food&#x22; for dinner and feels exhausted every day.&nbsp; Following a divorce 3 years ago, the patient was diagnosed with major depressive disorder, which improved after a few months of treatment with paroxetine.&nbsp; The patient has a history of separation anxiety disorder as a child, which resolved with psychotherapy.&nbsp; Family history is significant for generalized anxiety disorder in his mother.&nbsp; Physical examination and laboratory evaluation are normal.&nbsp; After discussion of treatment options, the patient decides to start sertraline.&nbsp; His symptoms resolve by the follow-up appointment 6 months later.&nbsp; Which of the following features is an indication for long-term maintenance of antidepressant therapy in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>For many patients, <strong>major depressive disorder</strong> is a recurrent illness, as seen in this case.&nbsp; Recommendations for long-term maintenance antidepressant therapy should take the <strong>number</strong> of lifetime depressive <strong>episodes</strong> into account because prior history of episodes is the most consistently identified <strong>risk factor for future episodes</strong>.</p><p>Patients with <strong>&#8805;2 episodes</strong> are candidates for <strong>maintenance antidepressant therapy</strong> (ie, continuing antidepressants for 1-3 years).&nbsp; Continuing treatment indefinitely can also be considered in some cases (eg, &#8805;3 lifetime depressive episodes) .&nbsp; Other indications for maintenance therapy include early age of onset, greater severity, suicidality, and the presence of severe, ongoing psychosocial stressors or persistent residual depressive symptoms.</p><p>In contrast to patients with recurrent episodes, patients with a single episode of major depressive disorder should continue antidepressant treatment for a period of 6 months following response.&nbsp; If remission is sustained, the antidepressant can then be tapered and discontinued.</p><p><strong>(Choice A)</strong>&nbsp; Early age of onset (&lt;20 years) is a risk factor for recurrence.</p><p><strong>(Choice B)</strong>&nbsp; Chronic depressive episodes (lasting &gt;2 years) are an indication for maintenance therapy.&nbsp; However, this patient&#39;s current and prior depressive episodes lasted only a few months.</p><p><strong>(Choice C)</strong>&nbsp; A link between family history of anxiety disorders and the risk of recurrence of mood episodes has not been demonstrated.</p><p><strong>(Choice D)</strong>&nbsp; Patients who have an active comorbid psychiatric disorder or a history of childhood abuse are at an increased risk for depressive recurrence.&nbsp; However, this patient has no history of abuse, and his history of separation anxiety disorder is remote.</p><p><strong>(Choice F)</strong>&nbsp; There is no evidence that the presence of atypical depressive features (eg, hypersomnia, hyperphagia, mood reactivity) increases the risk of recurrence.</p><p><strong>Educational objective:</strong><br>Major depressive disorder is frequently recurrent.&nbsp; Long-term maintenance antidepressant therapy is indicated for patients with &#8805;2 major depressive episodes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Age of onset of initial depressive episode",
                    "choiceNumber": 1,
                    "correctTaken": 451,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Duration of current depressive episode",
                    "choiceNumber": 2,
                    "correctTaken": 1663,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Family history of anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 166,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "History of separation anxiety disorder",
                    "choiceNumber": 4,
                    "correctTaken": 447,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Number of prior depressive episodes",
                    "choiceNumber": 5,
                    "correctTaken": 12638,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Presence of atypical depressive features",
                    "choiceNumber": 6,
                    "correctTaken": 1808,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "442,485,true,-1,1*507,520,true,-1,1*562,595,true,-1,1*598,1082,true,-1,1*1094,1125,true,-1,1*1170,1261,true,-1,1*1798,1875,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23111147",
                    "mediaDataId": 0,
                    "title": "Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23111147",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27786144",
                    "mediaDataId": 0,
                    "title": "Predicting relapse after antidepressant withdrawala systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27786144",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 77,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 17173,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1343,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 4879,
            "questionIndex": 4879,
            "questionText": "<p>A 58-year-old woman comes to the emergency department after developing a headache following a gourmet meal that included heavy sauces and wine.&nbsp; On arrival, the patient is anxious and tremulous.&nbsp; Medical history includes recurrent major depression with psychotic features, generalized anxiety disorder, and osteoarthritis.&nbsp; Medications include phenelzine and risperidone, which she takes as prescribed.&nbsp; Her depression has been in remission for the past 5 years.&nbsp; The patient&#39;s other medications include ibuprofen.&nbsp; She does not use illicit drugs.&nbsp; Which of the following is the most likely finding on physical examination?</p>",
            "questionHeader": "",
            "explanationText": "<p>The acute onset of <strong>headache following a meal</strong> in a patient treated with <strong>phenelzine</strong> raises concern for <strong>hypertensive crisis</strong>.&nbsp; Phenelzine is one of several available <strong>monoamine oxidase inhibitors (MAOIs)</strong>, an older class of antidepressant drugs used primarily for the treatment of refractory depression.&nbsp; In the brain, they inhibit the metabolism of the monoamines norepinephrine, dopamine, and serotonin.&nbsp; MAOIs are not typically used as first-line therapy due to drug-drug interactions and <strong>dietary restrictions</strong> involving foods containing <strong>tyramine</strong>.</p><p>Tyramine may be present in aged cheeses, aged or cured meats, aged or fermented soy products, overripe fruits, and some alcoholic beverages.&nbsp; Tyramine is a sympathomimetic monoamine that can facilitate the release of other sympathomimetic monoamines (eg, adrenaline/epinephrine) systemically.&nbsp; Tyramine metabolism is inhibited in the presence of MAOIs, causing an increased <strong>sympathomimetic (ie, adrenergic) effect</strong> that can result in severe hypertension.&nbsp; This commonly presents first as a headache but can lead to intracranial bleeding, stroke, and death.</p><p><strong>(Choices A and F)</strong>&nbsp; Hyperreflexia and myoclonus are characteristic of serotonin syndrome, which can occur when MAOIs are combined with serotonergic antidepressants, illicit substances, or other medications with serotonergic effects (eg, selective serotonin reuptake inhibitors, meperidine).&nbsp; The combination of an MAOI and tyramine does not usually result in serotonin syndrome.</p><p><strong>(Choice C)</strong>&nbsp; Hyperthermia is not a typical feature of hypertensive crisis.</p><p><strong>(Choice D)</strong>&nbsp; Hypotension is a fairly common side effect of MAOIs and may lead to dizziness but is not related to any dietary interaction.</p><p><strong>(Choice E)</strong>&nbsp; Diffuse muscle rigidity is seen in neuroleptic malignant syndrome, a rare medical complication of antipsychotics that typically occurs early in treatment and would be unlikely to appear in a patient who has been on a stable dose of risperidone for years.</p><p><strong>Educational objective:</strong><br>Patients taking monoamine oxidase inhibitors such as phenelzine should avoid foods rich in tyramine as the interaction of such food-drug combinations can result in hypertensive crisis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 23731,
            "topic": "Monoamine oxidase inhibitors",
            "titleId": 23731,
            "title": "Monoamine oxidase inhibitors",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hyperreflexia",
                    "choiceNumber": 1,
                    "correctTaken": 1580,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypertension",
                    "choiceNumber": 2,
                    "correctTaken": 12252,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperthermia",
                    "choiceNumber": 3,
                    "correctTaken": 1332,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypotension",
                    "choiceNumber": 4,
                    "correctTaken": 312,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Muscle rigidity",
                    "choiceNumber": 5,
                    "correctTaken": 796,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Myoclonus",
                    "choiceNumber": 6,
                    "correctTaken": 717,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "152,327,true,-1,1*574,1129,true,-1,1*1149,1217,true,-1,1*1407,1417,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23934742",
                    "mediaDataId": 0,
                    "title": "Current place of monoamine oxidase inhibitors in the treatment of depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23934742",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22951238",
                    "mediaDataId": 0,
                    "title": "Dietary restrictions and drug interactions with monoamine oxidase inhibitors:  an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22951238",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 45,
            "othersAvgTimeSpent": 38,
            "notes": null,
            "peopleTaken": 16989,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 744,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 14404,
            "questionIndex": 15813,
            "questionText": "<p>A 42-year-old woman, gravida 1 para 1, comes to the office for evaluation of insomnia following the birth of her son 5 weeks ago.&nbsp; The patient says she wakes up each night to breastfeed him but is unable to go back to sleep.&nbsp; She stays up most of the night thinking, &#x22;Why did I have a child so late in life?&nbsp;I&#39;m already failing as a mother.&#x22;&nbsp; The patient has a decreased appetite and no interest in seeing friends or family members other than her mother.&nbsp; She has no medical history and the delivery was uncomplicated.&nbsp; Physical examination shows no abnormalities.&nbsp; On mental status examination, the patient appears&nbsp;restless and is tearful.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s insomnia, loss of appetite, lack of interest in seeing friends, depressed mood/tearfulness, restlessness (ie, psychomotor agitation), and guilt about her ability to care for her son are most likely due to a <strong>major depressive episode with postpartum onset</strong>.&nbsp; Postpartum depression is diagnosed using the <strong>same diagnostic criteria</strong> for diagnosing a <strong>major depressive episode</strong> (&#8805;2 weeks of at least 5 of 9 symptoms that include <strong>depressed mood</strong> plus <strong>SIGECAPS</strong>: <strong>S</strong>leep disturbance, loss of <strong>I</strong>nterest, <strong>G</strong>uilt/worthlessness, low <strong>E</strong>nergy, impaired <strong>C</strong>oncentration, change in <strong>A</strong>ppetite, <strong>P</strong>sychomotor retardation or agitation, and <strong>S</strong>uicidal thoughts).&nbsp; Comorbid anxiety is common in postpartum depression, frequently revolving around anxiety about the infant&#39;s health and concerns about being a good mother.&nbsp; Screening for postpartum depression should be performed routinely at postpartum checkups.</p><p>In comparison to postpartum depression, postpartum blues is a more common condition characterized by mild depressive symptoms (eg, tearfulness, irritability) that develop 2-3 days following delivery <strong>(Choice E)</strong>.&nbsp; It is a normal and self-limited response that typically peaks at 5 days postpartum and resolves within 2 weeks.&nbsp; In contrast, this patient&#39;s symptoms have persisted beyond 2 weeks and are sufficiently severe to diagnose a major depressive episode.</p><p><strong>(Choice A)</strong>&nbsp; Although being a new mother is a significant stressor, when symptoms are severe enough to meet criteria for a major depressive episode, adjustment disorder is not diagnosed.</p><p><strong>(Choice B)</strong>&nbsp; Postpartum medical complications (eg, anemia, thyroiditis) can cause mood symptoms.&nbsp; However, this patient has a normal physical examination and no history of medical problems or obstetrical complications, making anxiety due to a medical condition less likely.</p><p><strong>(Choice C)</strong>&nbsp; This patient&#39;s anxiety revolves around her ability to care for her baby.&nbsp; Generalized anxiety disorder is characterized by pervasive anxiety about multiple issues that lasts &#8805;6 months.</p><p><strong>Educational objective:</strong><br>Postpartum depression should be differentiated from postpartum blues, a milder and self-limited form of depression that peaks at 5 days and resolves within 2 weeks.&nbsp; Postpartum depression is diagnosed using the same diagnostic criteria for a major depressive episode outside the postpartum period.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 1,
                    "correctTaken": 1593,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anxiety due to a general medical condition",
                    "choiceNumber": 2,
                    "correctTaken": 40,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 75,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive episode",
                    "choiceNumber": 4,
                    "correctTaken": 12571,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum blues",
                    "choiceNumber": 5,
                    "correctTaken": 2797,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "137,226,true,-1,1*1575,1658,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24943697",
                    "mediaDataId": 0,
                    "title": "Postpartum depression: current status and future directions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24943697",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23394227",
                    "mediaDataId": 0,
                    "title": "Concise review for physicians and other clinicians: postpartum depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23394227",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 147,
            "othersAvgTimeSpent": 40,
            "notes": null,
            "peopleTaken": 17076,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 628,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 11217,
            "questionIndex": 12369,
            "questionText": "<p>A 27-year-old man comes to the office at his wife&#39;s insistence due to issues with concentration that are affecting his job performance.&nbsp; The patient works in information technology and has been easily distracted and unable to complete his assignments after returning from a business trip 4 weeks ago.&nbsp; The trip was stressful because it involved giving multiple presentations.&nbsp; Since his return, instead of working on current projects with assigned deadlines, he has spent hours developing new computer programs and is at risk of losing his job.&nbsp; He hardly sleeps at night and is increasingly anxious and irritable, behavior that is uncharacteristic.&nbsp; Last week, the patient became angry when his wife was skeptical of his idea to leave his job and start an internet company with no resources or investors.&nbsp; The patient has a history of attention-deficit hyperactivity disorder, for which he was treated with cognitive-behavioral therapy for 4 years beginning at age 8.&nbsp; He used cocaine in his early 20s but has not used illicit drugs in 3 years, apart from marijuana on occasion, which he says &#x22;helps me feel less anxious.&#x22;&nbsp; Family history is significant for depression in his mother.&nbsp; On physical examination, the patient is cooperative but appears tense and anxious.&nbsp; He is talkative, easily distracted, and has difficulty sitting still; at one point he gets up to walk around the room.&nbsp; The patient has no psychotic symptoms or suicidal ideation.&nbsp; Urine drug screen is negative.&nbsp; Which of the following is the most likely explanation of the patient&#39;s recent behavior?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34762\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Manic episode</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>&ge;1 week of elevated or irritable mood &amp; increased energy/activity</li><li>&ge;3 of the following symptoms (4 if mood is irritable only) (<strong>DIGFAST</strong> mnemonic):<ul style=\"list-style-type:circle;\"><li><strong>Distractibility</strong></li><li><strong>Impulsivity</strong>/indiscretion, risky behavior</li><li><strong>Grandiosity</strong></li><li><strong>Flight of ideas</strong>/racing thoughts</li><li>Increased <strong>activity</strong>/psychomotor agitation</li><li>Decreased need for <strong>sleep</strong></li><li><strong>Talkativeness</strong>/pressured speech</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Severity</strong></p></td><td><ul><li>Impaired psychosocial function</li><li>May have psychotic features (hallucinations, delusions)</li><li>May require hospitalization</li></ul></td></tr></tbody></table></div><p>This patient&#39;s 4-week episode of <strong>irritability</strong>, <strong>talkativeness</strong>, <strong>decreased</strong> need for <strong>sleep</strong>, <strong>distractibility</strong>, and excessive <strong>involvement</strong> in <strong>new and risky projects</strong> is resulting in both relational and occupational impairment and is suggestive of a <strong>manic episode</strong> of bipolar I disorder.&nbsp; In manic episodes of bipolar I disorder, the predominant mood may be irritability rather than euphoria. This patient&#39;s difficulty sitting still and hyperactivity during the interview are also characteristic.&nbsp; History of a major depressive episode is not required for diagnosis of bipolar I disorder, although most patients will later have multiple <a href=\"14074\">manic and depressive episodes</a>.</p><p>Bipolar disorder and attention-deficit hyperactivity disorder (ADHD) can be difficult to differentiate due to overlapping symptoms (eg, distractibility, hyperactivity, impulsivity), and the conditions can be comorbid.&nbsp; However, ADHD has a chronic (not episodic) course and presents with ongoing difficulties that begin in childhood.&nbsp; It would not explain this patient&#39;s <strong>abrupt change</strong> in <strong>behavior</strong> compared to his baseline 4 weeks ago <strong>(Choice B)</strong>.&nbsp; More prominent mood symptoms and, in some cases, psychotic symptoms are other features that distinguish bipolar disorder from ADHD.</p><p><strong>(Choice A)</strong>&nbsp; Adjustment disorder is diagnosed when symptoms occur in direct response to an identified psychosocial stressor and cannot be explained by another disorder.&nbsp; Although this patient&#39;s symptoms began shortly after a stressful business trip, his behavior is consistent with a manic episode of bipolar disorder.</p><p><strong>(Choice D)</strong>&nbsp; Although patients with generalized anxiety disorder may experience irritable mood, poor sleep, and difficulty concentrating, this patient does not display other key features (eg, &#8805;6 month of uncontrollable concern about multiple daily issues).</p><p><strong>(Choice E)</strong>&nbsp; Although cocaine and other drugs with stimulant properties can cause manic symptoms, this patient has not used any illicit drugs other than marijuana for 3 years.&nbsp; Marijuana use can result in irritability and anxiety, but it would not cause the other symptoms of mania evident in this patient (eg, hyperactivity, decreased need for sleep, increased goal-directed activity, pressured speech).</p><p><strong>Educational objective:</strong><br>Patients with bipolar disorder may exhibit distractibility and hyperactivity that are difficult to distinguish from symptoms of attention-deficit hyperactivity disorder.&nbsp; An episodic (not chronic) course and prominent mood symptoms are more characteristic of bipolar disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 1,
                    "correctTaken": 739,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Attention-deficit hyperactivity disorder",
                    "choiceNumber": 2,
                    "correctTaken": 2089,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar disorder",
                    "choiceNumber": 3,
                    "correctTaken": 11674,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 4,
                    "correctTaken": 429,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Substance-induced mood disorder",
                    "choiceNumber": 5,
                    "correctTaken": 1139,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "806,911,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26084666",
                    "mediaDataId": 0,
                    "title": "Bipolar disorder and ADHD: comorbidity and diagnostic distinctions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26084666",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25406047",
                    "mediaDataId": 0,
                    "title": "Adult ADHD vs. bipolar disorder in the DSM-5 era: a challenging differentiation for clinicians.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25406047",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 174,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 16070,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1723,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 10829,
            "questionIndex": 11959,
            "questionText": "<p>A 68-year-old man is admitted to a rehabilitation unit following a stroke that resulted in right-sided weakness and facial droop.&nbsp; Medical history includes hypertension, coronary artery disease, osteoarthritis, and prostate cancer in remission.&nbsp; Prior to the stroke, the patient had retired to care for his wife, who has early-onset dementia.&nbsp; He has shown little effort over the past 3 weeks and has recently refused rehabilitation services, saying, &#x22;What&#39;s the point?&#x22;&nbsp; The patient&#39;s son, who comes to visit a few times a week, says, &#x22;Ever since last month&#39;s stroke, he seems so resigned and barely talks when I visit.&nbsp; He seems uninterested in hearing about the grandchildren he adores and has asked his friends not to visit.&#x22;&nbsp; The patient says he has had low energy, decreased concentration, and difficulty sleeping since the stroke.&nbsp; He says, &#x22;Of course I feel sad, with all my medical problems and my wife&#39;s condition.&nbsp; I don&#39;t know how someone wouldn&#39;t feel this way.&#x22;&nbsp; He has no suicidal ideation.&nbsp; Which of the following is the most appropriate response to the patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s sad and hopeless mood, anhedonia (eg, no interest in family and friends), low energy, impaired concentration, and sleep difficulty meet the criteria for <a href=\"17482\">major depressive disorder</a>.&nbsp; <strong>Poststroke depression</strong> occurs in nearly one-third of stroke survivors.&nbsp; However, it is often overlooked in patients recovering from a stroke, contributing to reduced quality of life, <strong>decreased adherence</strong> to treatment, <strong>poorer functional outcomes</strong>, and increased mortality.</p><p><strong>Early treatment</strong> of poststroke depression with <strong>antidepressants</strong> (eg, selective serotonin reuptake inhibitors) and/or psychotherapy can alleviate depressive symptoms and enhance physical and cognitive recovery.&nbsp; Therefore, treatment should be offered without delay <strong>(Choice D)</strong>.&nbsp; Patients recovering from a stroke and its complications experience wide-ranging and difficult emotions.&nbsp; Thoughtfully initiating the topic of depression treatment should include empathically validating a patient&#39;s experience (eg, &#x22;experiencing depression after a stroke is common&#x22;) followed by education about treatment options (eg, &#x22;there are treatments that can help&#x22;).</p><p><strong>(Choice B)</strong>&nbsp; Normalizing the patient&#39;s experience is important; however, untreated poststroke depression can have a profound negative impact on stroke recovery, future functioning, and quality of life.&nbsp; Attributing this patient&#39;s condition to a normal grief reaction underestimates the severity of his major depressive disorder and potentially deprives him of effective antidepressant pharmacotherapy and/or psychotherapy intervention.</p><p><strong>(Choice C)</strong>&nbsp; Behavioral activation benefits mood, and physical therapy will be necessary to improve strength; however, physical activity alone is not expected to manage this patient&#39;s poststroke depressive symptoms and should not be offered in place of first-line effective interventions (eg, antidepressants, psychotherapy).</p><p><strong>(Choice E)</strong>&nbsp; Attending a support group may be a useful adjunct to antidepressant treatment and can help patients feel supported in recovery.&nbsp; However, support groups are not sufficient substitutes for first-line treatment options of major depressive disorders.</p><p><strong>Educational objective:</strong><br>Poststroke depression is common, underdiagnosed, and associated with increased morbidity and mortality.&nbsp; Patients benefit from empathic validation of their symptoms followed by education about treatment options.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24827,
            "topic": "Physician patient communication",
            "titleId": 24827,
            "title": "Physician patient communication",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "1",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Experiencing depression after a stroke is common and can make recovery even more difficult; there are treatments that can help.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 7574,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Most people in your situation would feel the same way; your sadness is part of a normal grief reaction to your new physical limitations.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 1686,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Physical activity can have a positive effect on mood; participating in rehabilitation can improve your strength and your outlook.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 503,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Your recovery has been difficult given everything that has happened, but you will feel better as you heal emotionally and physically.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 736,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;You&#39;re trying to process a lot of major life changes; joining a support group can help you connect with other stroke survivors.&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 1664,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "101",
                    "mediaDataId": 0,
                    "title": "Major depressive disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26684921",
                    "mediaDataId": 0,
                    "title": "Post-stroke depression: a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26684921",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22901370",
                    "mediaDataId": 0,
                    "title": "Post-stroke depression: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22901370",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 139,
            "othersAvgTimeSpent": 40,
            "notes": null,
            "peopleTaken": 12163,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 666,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 18876,
            "questionIndex": 20355,
            "questionText": "<p>A 63-year-old man is brought to the emergency department due to restlessness and altered mental status.&nbsp; His wife reports that the patient awakened at 6:00 AM agitated and slightly confused.&nbsp; Over the past 2 hours, his symptoms have worsened.&nbsp; She states that he was well the previous day but went to his primary care doctor due to a persistent, dry cough for 3 weeks following an upper respiratory tract infection.&nbsp; The patient was prescribed dextromethorphan and an albuterol inhaler.&nbsp; He has a history of major depressive disorder that is well controlled with fluoxetine.&nbsp; Temperature is 38.3 C (101 F), blood pressure is 160/90 mm Hg, pulse is 112/min, and respirations are 22/min.&nbsp; Pulse oximetry is 100% on room air.&nbsp; The patient is agitated and confused.&nbsp; Pupils are dilated, and lungs are clear to auscultation bilaterally.&nbsp; Hyperreflexia and ankle clonus are noted on neurological examination.&nbsp; Which of the following is the most appropriate initial therapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33501\"><table class=\"table-default-style table-header-footer-style\" style=\"width:100.0%\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Serotonin toxicity</strong></p></td></tr><tr><td><p align=\"center\"><strong>Causes</strong></p></td><td><ul><li>Serotonergic medications, especially in combination (eg, SSRI/SNRI, TCA, tramadol)</li><li>Drug interactions: serotonergic medication &amp; MAOI or linezolid</li><li>Intentional overdose of serotonergic medications</li><li>Serotonergic substances (eg, MDMA, dextromethorphan, amphetamines)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Mental status changes (eg, anxiety, agitation, delirium)</li><li>Autonomic dysregulation (eg, diaphoresis, hypertension, tachycardia, hyperthermia, vomiting, diarrhea)</li><li>Neuromuscular hyperactivity (eg, tremor, myoclonus, hyperreflexia)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Discontinuation of all serotonergic medications</li><li>Supportive care, sedation with benzodiazepines</li><li>Serotonin antagonist (cyproheptadine) if supportive measures fail</li><li>Immediate sedation, paralysis &amp; tracheal intubation if temperature &gt;41.1 C (106 F)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>MAOI</strong> = monoamine oxidase inhibitor; <strong>SNRI</strong> = serotonin-norepinephrine reuptake inhibitor; <strong>SSRI </strong>= selective serotonin reuptake inhibitor; <strong>TCA</strong> = tricyclic antidepressant.</p></td></tr></tbody></table></div><p>This patient taking a selective serotonin inhibitor (SSRI) has altered mental status, autonomic instability (eg, hyperthermia, hypertension, tachycardia, mydriasis), and neuromuscular excitability (eg, hyperreflexia, ankle clonus), a triad concerning for <strong>serotonin toxicity</strong>.&nbsp; Although it typically follows an increased SSRI (eg, <strong>fluoxetine</strong>) dosage, serotonin toxicity can also be precipitated by concomitant use of another serotonergic agent.&nbsp; This patient recently began taking the antitussive <strong>dextromethorphan</strong>, which primarily activates sigma opioid receptors to inhibit cough but also has serotonergic activity at the 5-hydroxytryptophan (5-HTA) 2 receptors.</p><p>Management often includes:</p><ul><li><p><strong>Discontinuation</strong> of all <strong>serotonergic medications</strong></p></li><li><p>Management of severe hypertension with <strong>short-acting antihypertensives</strong> (eg, esmolol)</p></li><li><p>Intravenous hydration, and evaporative and convective <strong>cooling</strong> (eg, fanning, water mist).&nbsp; Antipyretics are <strong>not</strong> used because hyperthermia is due to sustained muscle contraction, not elevations in the hypothalamic temperature set point.</p></li><li><p><strong>Benzodiazepines</strong> (eg, lorazepam) to improve agitation, decrease muscle contraction (which reduces hyperthermia), and decrease blood pressure and heart rate</p></li></ul><p>In patients who are unresponsive to benzodiazepines and supportive care, <strong>cyproheptadine</strong> is used to lower the serotonergic activity through antagonism of 5-HT1A and 5-HT2A receptors.&nbsp; Serotonin toxicity can have a relatively rapid onset and progression; some patients require intubation and sedation (eg, for severe hyperthermia).</p><p><strong>(Choice A)</strong>&nbsp; Bromocriptine, a dopamine agonist, is used to treat neuroleptic malignant syndrome (NMS).&nbsp; Although NMS can also present with hyperthermia and autonomic dysregulation, severe muscle rigidity is typically a prominent feature; myoclonus and hyperreflexia are less common.</p><p><strong>(Choice B)</strong>&nbsp; Haloperidol, an antipsychotic that treats psychosis and agitation, should not be used in serotonin toxicity because its anticholinergic properties prevent the dissipation of body heat, exacerbating hyperthermia.</p><p><strong>(Choice C)</strong>&nbsp; Although pneumonia (treated with levofloxacin) can present with fever and altered mental status after upper respiratory tract symptoms, this patient&#39;s normal oxygen saturation and clear lungs make pneumonia less likely.&nbsp; Also, it would be unusual for pneumonia to develop suddenly after 3 weeks of dry cough, and dilated pupils and neuromuscular excitability would not be expected.</p><p><strong>(Choice E)</strong>&nbsp; Physostigmine is sometimes used to treat anticholinergic toxicity, which can cause delirium, mydriasis, hyperthermia, and hypertension.&nbsp; However, hyperreflexia and clonus would be unexpected, and this patient&#39;s combination of serotonergic medications makes serotonin toxicity more likely.</p><p><strong>Educational objective:</strong><br>Serotonin toxicity is characterized by mental status changes, autonomic dysregulation, and neuromuscular excitability.&nbsp; Management includes discontinuation of serotonergic medications, hydration, cooling, and blood pressure control.&nbsp; Benzodiazepines are used to decrease agitation and muscle contractions.&nbsp; Cyproheptadine is used to decrease central serotonergic activity.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 8437,
            "topic": "Serotonin toxicity",
            "titleId": 8437,
            "title": "Serotonin toxicity",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bromocriptine",
                    "choiceNumber": 1,
                    "correctTaken": 1066,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Haloperidol",
                    "choiceNumber": 2,
                    "correctTaken": 294,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Levofloxacin",
                    "choiceNumber": 3,
                    "correctTaken": 38,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lorazepam",
                    "choiceNumber": 4,
                    "correctTaken": 2757,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Physostigmine",
                    "choiceNumber": 5,
                    "correctTaken": 820,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2861,2875,true,-1,1*2978,3073,true,-1,1*3480,3617,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24358002",
                    "mediaDataId": 0,
                    "title": "Serotonin syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24358002",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 66,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 5107,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 43,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 10769,
            "questionIndex": 11897,
            "questionText": "<p>A 33-year-old man is hospitalized for depression with psychotic features.&nbsp; The patient had been on outpatient phenelzine therapy for major depressive disorder but stopped taking the medication 3 weeks ago because he did not feel that it was helping.&nbsp; Two days ago, he was brought to the emergency department due to worsening depressive symptoms and new auditory hallucinations.&nbsp; He was started on citalopram and risperidone and admitted to the inpatient psychiatric unit.&nbsp; He has not been receiving any&nbsp;other medications.&nbsp; This morning, he was found to have acute-onset confusion and high fever.&nbsp; Temperature is 39.4 C (102.9 F), blood pressure is 160/80 mm Hg, pulse is 118/min, and respirations are 16/min.&nbsp; On examination, the patient is disoriented and unable to attend to the interview.&nbsp; He has severe muscle stiffness but no hyperreflexia.&nbsp; The remainder of the examination is within normal limits.&nbsp; Laboratory tests are ordered, but results are not yet available.&nbsp; Which of the following is the most likely provisional diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35982\"><table class=\"table-default-style\" style=\"width:567px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Neuroleptic malignant syndrome</strong></p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Signs/symptoms</strong></p></td><td><ul><li>Fever (&gt;40 C [104 F] common)</li><li>Confusion</li><li>Muscle rigidity (generalized)</li><li>Autonomic instability (eg, abnormal vital signs, sweating)</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Treatment</strong></p></td><td><ul><li>Stop antipsychotics or restart dopamine agents</li><li>Supportive care (eg, hydration, cooling),&nbsp;intensive care unit</li><li>Dantrolene or bromocriptine if refractory</li></ul></td></tr></tbody></table></div><p>This patient&#39;s development of confusion, fever, and severe rigidity in the setting of recent initiation of the antipsychotic risperidone is suggestive of <strong>neuroleptic malignant syndrome</strong> (NMS).&nbsp; <a href=\"3377\">NMS</a> is characterized by autonomic instability (with notably high <strong>fevers</strong>), delirium, generalized <strong>rigidity</strong> (often severe), rhabdomyolysis (with increased serum creatine kinase), and leukocytosis.&nbsp; It is a potentially life-threatening medical condition that can occur any time after treatment with an antipsychotic.&nbsp; Although most often seen with high-potency first-generation antipsychotics (eg, haloperidol), the syndrome can occur with all antipsychotics.&nbsp; It can develop over 1-3 days, with delirium often being the first manifestation.</p><p>Serotonin syndrome (SS) can be difficult to distinguish from NMS.&nbsp; SS is characterized by neuromuscular hyperactivity (eg, tremor, hyperreflexia, myoclonus), rather than the severe, generalized rigidity seen in this patient <strong>(Choice E)</strong>.&nbsp; SS is typically due to a combination of serotonergic medications or the interaction of serotonergic medications (eg, citalopram) and monoamine oxidase inhibitors (MAOIs) (eg, switching from an MAOI to an SSRI with less than the required 2-week washout period).&nbsp; This patient had an adequate washout period given that he stopped the MAOI phenelzine 3 weeks ago before starting citalopram.</p><p><strong>(Choice A)</strong>&nbsp; Although malignant catatonia may share some features of NMS, it has an insidious onset and usually presents with a prodrome of motor agitation.&nbsp; NMS is more likely given the rapid onset of symptoms following initiation of an antipsychotic.</p><p><strong>(Choice B)</strong>&nbsp; Malignant hyperthermia may occur in genetically susceptible patients, leading to hypercarbia, muscle rigidity, and hyperthermia in the setting of perioperative exposure to volatile anesthetics or succinylcholine.&nbsp; Onset of malignant hyperthermia is much more rapid than that of NMS.</p><p><strong>(Choice C)</strong>&nbsp; Abrupt discontinuation of any antidepressant may result in both medical and neurological symptoms.&nbsp; However, if present, symptoms occur in the first few days after discontinuation and often subside after 2-3 weeks.</p><p><strong>Educational objective:</strong><br>Neuroleptic malignant syndrome is a life-threatening condition associated with the use of antipsychotics.&nbsp; It is characterized by delirium, high fever, autonomic instability, severe rigidity, elevated creatine kinase, and leukocytosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 7877,
            "topic": "Neuroleptic malignant syndrome",
            "titleId": 7877,
            "title": "Neuroleptic malignant syndrome",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Malignant catatonia",
                    "choiceNumber": 1,
                    "correctTaken": 300,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malignant hyperthermia",
                    "choiceNumber": 2,
                    "correctTaken": 492,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Monoamine oxidase inhibitor discontinuation symptoms",
                    "choiceNumber": 3,
                    "correctTaken": 334,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neuroleptic malignant syndrome",
                    "choiceNumber": 4,
                    "correctTaken": 13703,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serotonin syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 2089,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "76,103,true,-1,1*245,260,true,-1,1*323,364,true,-1,1*678,751,true,-1,1*1733,1972,true,-1,1*2199,2267,true,-1,1*2710,2752,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26411967",
                    "mediaDataId": 0,
                    "title": "Neuroleptic malignant syndrome: a review from a clinically oriented perspective.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26411967",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 72,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16918,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 442,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 13666,
            "questionIndex": 15056,
            "questionText": "<p>A 58-year-old woman comes to the office due to depressed mood and hopelessness for the past 2 months.&nbsp; She has no interest in her hobbies or exercising and feels emotionally detached from her family and friends.&nbsp; The patient awakens every night at 2 AM and is up for the day at 4 AM.&nbsp; Her appetite is poor, and her children and husband have to remind her to eat.&nbsp; Her symptoms have caused her to take a leave of absence from work, and she has difficulty sustaining her attention to read a book or follow a television program.&nbsp; She has no suicidal thoughts.&nbsp; The patient has a history of depression beginning at age 22 and has had 5 lifetime episodes of major depression with one psychiatric hospitalization following a suicide attempt at age 32.&nbsp; She has not been hospitalized since then.&nbsp; Previous treatments have included paroxetine, escitalopram, and venlafaxine.&nbsp; She is not on any medication currently.&nbsp; Major depressive disorder is diagnosed, and the patient is started on venlafaxine as she recalls having an excellent response to this medication in the past.&nbsp; At her 2-week follow-up, she is showing signs of improvement.&nbsp; Which of the following is the most appropriate treatment plan for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Major depressive disorder</strong> is a highly recurrent illness for most patients.&nbsp; Due to the high risk of recurrence, patients with &#8805;2 episodes are candidates for maintenance antidepressant treatment (ie, continuing antidepressants beyond the continuation phase of ~6 months following remission). &nbsp;Other indications for maintenance therapy (due to high risk of recurrence) include early age of onset (&#8804;18), persistent residual depressive symptoms, and comorbid psychiatric disorders.&nbsp; Maintenance therapy can be continued for ~1-3 years.</p><p>However, patients with a history of <strong>highly recurrent illness</strong> (eg, &#8805;3 lifetime depressive episodes), <strong>chronic episodes</strong> (&#8805;2 years), severe ongoing psychosocial stressors, or <strong>severe episodes</strong> (eg, suicide attempts) are candidates for <strong>maintaining antidepressant</strong> treatment <strong>indefinitely</strong>.</p><p>This patient&#39;s highly recurrent and severe episodes (ie, 5 previous major depressive episodes and a suicide attempt) make her an appropriate candidate for maintaining antidepressant pharmacotherapy indefinitely.&nbsp; Recurrent major depression may be conceptualized as a chronic illness similar to other chronic medical diseases (eg, hypertension, diabetes) that often require long-term medications.</p><p><strong>(Choice A)</strong>&nbsp; The dose that achieves remission should be maintained.&nbsp; Reducing the dose had been associated with an increased risk of recurrence.</p><p><strong>(Choices B, C, and D)</strong>&nbsp; Given the highly recurrent nature of this patient&#39;s illness, maintenance pharmacotherapy is indicated.&nbsp; If the decision is made to discontinue medication, a gradual taper over several weeks to months is preferable.&nbsp; Patients with a history of recurrent episodes who discontinue antidepressants should be monitored closely, and antidepressant therapy should be reinstituted at the first signs of recurrence.</p><p><strong>Educational objective:</strong><br>Major depressive disorder is often a recurrent illness.&nbsp; Patients with &#8805;3 lifetime depressive episodes, severe episodes (eg, suicide attempts), or episodes lasting &#8805;2 years are candidates for lifelong antidepressant treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Continue venlafaxine for 1 year, then maintain at a reduced dose",
                    "choiceNumber": 1,
                    "correctTaken": 1179,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue venlafaxine for 1 year, then taper gradually",
                    "choiceNumber": 2,
                    "correctTaken": 710,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue venlafaxine for 6 months after symptom remission, then taper gradually",
                    "choiceNumber": 3,
                    "correctTaken": 2925,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue venlafaxine for 6 weeks, then discontinue",
                    "choiceNumber": 4,
                    "correctTaken": 79,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue venlafaxine indefinitely",
                    "choiceNumber": 5,
                    "correctTaken": 12113,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "104,319,true,-1,1*397,561,true,-1,1*562,841,true,-1,1*1619,1811,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23111147",
                    "mediaDataId": 0,
                    "title": "Recurrence of major depressive disorder and its predictors in the general population:  results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23111147",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24717376",
                    "mediaDataId": 0,
                    "title": "Review of maintenance trials for major depressive disorder:  a 25-year perspective from the US Food and Drug Administration.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24717376",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20371029",
                    "mediaDataId": 0,
                    "title": "Rationale for, barriers to, and appropriate medication for the long-term treatment of depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20371029",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27786144",
                    "mediaDataId": 0,
                    "title": "Predicting relapse after antidepressant withdrawal - a systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27786144",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 64,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 17006,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 876,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 14520,
            "questionIndex": 15930,
            "questionText": "<p>A 15-year-old boy is brought to the office by his parents after he was caught shoplifting from an art supply store.&nbsp; The patient&#39;s father says, &#x22;For the past 2 weeks, my son has been impossible to manage.&nbsp; He has become loud, obnoxious, and rude.&nbsp; He skips doing household chores and stays up all night drawing in his room.&#x22;&nbsp; The boy&#39;s mother received a phone call from his school last week after he told his teacher that she was &#x22;incompetent&#x22; and that he intended to drop out.&nbsp; The patient tells the physician that he lives in &#x22;the most boring place in the world&#x22; and that his parents are jealous that he is &#x22;making a masterpiece that will be famous.&#x22;&nbsp; He has a history of a specific learning disorder with impairment in reading.&nbsp; Family history is significant for depression in a cousin and alcohol abuse in a paternal aunt.&nbsp; On mental status examination, the patient is easily distracted and struggles to sit still.&nbsp; He speaks quickly and becomes irritable when the physician attempts to clarify what he is saying.&nbsp; Routine laboratory tests are within normal range, and urine drug screen is negative.&nbsp; Which of the following is the most likely explanation for this patient&#39;s behavior?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34762\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Manic episode</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>&ge;1 week of elevated or irritable mood &amp; increased energy/activity</li><li>&ge;3 of the following symptoms (4 if mood is irritable only) (<strong>DIGFAST</strong> mnemonic):<ul style=\"list-style-type:circle;\"><li><strong>Distractibility</strong></li><li><strong>Impulsivity</strong>/indiscretion, risky behavior</li><li><strong>Grandiosity</strong></li><li><strong>Flight of ideas</strong>/racing thoughts</li><li>Increased <strong>activity</strong>/psychomotor agitation</li><li>Decreased need for <strong>sleep</strong></li><li><strong>Talkativeness</strong>/pressured speech</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Severity</strong></p></td><td><ul><li>Impaired psychosocial function</li><li>May have psychotic features (hallucinations, delusions)</li><li>May require hospitalization</li></ul></td></tr></tbody></table></div><p>This patient&#39;s presentation meets criteria for a <strong>manic episode</strong>, given the abrupt change in behavior&nbsp;accompanied by a decreased need for sleep, goal-directed activity, grandiosity, and risky behavior (shoplifting), all lasting for a 2-week period.&nbsp; Difficulty sitting still, distractibility, and rapid, loud speech are also characteristic.&nbsp; To diagnose <strong>bipolar disorder</strong>, a single manic episode is required, although most patients will go on to have multiple lifetime manic and depressive episodes.</p><p>Adolescents may exhibit mood changes and defiance as they test authority figures in the pursuit of autonomy.&nbsp; They may also have an unrealistic sense of their abilities and a willingness to engage in risky behavior without a full appreciation of the consequences.&nbsp; However, a <strong>decreased need for sleep</strong>, distractibility, and goal-directed activity that represents a <strong>distinct change from the patient&#39;s baseline</strong> should raise suspicion for mania and not be dismissed as normal adolescent behavior <strong>(Choice E)</strong>.&nbsp; Untreated bipolar disorder impacts psychosocial development and academic achievement and increases the risk for substance use, suicide, psychosis, and legal difficulties.</p><p><strong>(Choice A)</strong>&nbsp; Attention-deficit hyperactivity disorder can also present with distractibility, hyperactivity, impulsivity, and talkativeness.&nbsp; However, symptoms are chronic, lasting &#8805;6 months, with some symptoms presenting prior to age 12.&nbsp; In comparison, manic episodes are distinct occurrences, as in this case where the patient has experienced abrupt changes in behavior over a 2-week period.</p><p><strong>(Choices C and F)</strong>&nbsp; Oppositional defiant disorder presents with an irritable or angry mood, argumentativeness or deliberately annoying behavior, and vindictiveness.&nbsp; Conduct disorder is more severe, where the rights of others or societal norms are purposefully violated (eg, stealing, destroying property, assaulting others).&nbsp; Neither would explain an abrupt change in behavior, decreased need for sleep, and increased goal-directed activity.</p><p><strong>(Choice D)</strong>&nbsp; Patients with disruptive mood dysregulation disorder have temper outbursts that are out of proportion to the stimulus and inconsistent with developmental age.&nbsp; Symptoms manifest prior to age 10.</p><p><strong>Educational objective:</strong><br>Mania in adolescence may be confused with normal adolescent moodiness, defiance, overconfidence, and risk taking.&nbsp; However, an abrupt change from baseline, together with decreased need for sleep, distractibility, excessive goal-directed activity, and grandiosity, should raise suspicion for a manic episode.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Attention-deficit hyperactivity disorder",
                    "choiceNumber": 1,
                    "correctTaken": 1136,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar disorder",
                    "choiceNumber": 2,
                    "correctTaken": 11145,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Conduct disorder",
                    "choiceNumber": 3,
                    "correctTaken": 1929,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disruptive mood dysregulation disorder",
                    "choiceNumber": 4,
                    "correctTaken": 995,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal adolescent behavior",
                    "choiceNumber": 5,
                    "correctTaken": 200,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oppositional defiant disorder",
                    "choiceNumber": 6,
                    "correctTaken": 1808,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1713,1754,true,-1,1*1851,1938,true,-1,1*2563,2602,true,-1,1*2727,2743,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27735972",
                    "mediaDataId": 0,
                    "title": "Pediatric bipolar disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27735972",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 106,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 17214,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 572,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 4884,
            "questionIndex": 4884,
            "questionText": "<p>A 37-year-old man comes to the office for a follow-up visit.&nbsp; One month ago, he was diagnosed with type 2 diabetes mellitus and was started on metformin.&nbsp; Blood pressure is 130/80 mm Hg, fasting glucose is 122 mg/dL, and BMI is 29.1 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The patient looks rather dejected and admits that it has been difficult to come to terms with his diagnosis.&nbsp; He has tried to exercise, watch his oral intake, and quit smoking as was suggested, but lately he has felt unmotivated and without energy.&nbsp; The patient admits to feeling sad and guilty about his weight and smoking but is not sure he can do anything about it.&nbsp; He has been oversleeping and then spending much of the day in bed watching television or sleeping due to lack of energy.&nbsp; He has withdrawn from friends and family and took the last 2 weeks off from work because he did not &#x22;feel up to going.&#x22;&nbsp; The patient&#39;s ability to concentrate and pay attention to daily tasks is significantly impaired.&nbsp; Which of the following is the most appropriate pharmacotherapy?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient is suffering from a <strong>major depressive episode</strong> characterized by <u>&gt;</u>2 weeks of depressed mood, anhedonia, sleep disturbance, guilt, and impaired energy, motivation and concentration.&nbsp; Because no antidepressant has demonstrated superior efficacy, choice of medication is often based on other factors such as side effect profile and medical and psychiatric comorbidity.&nbsp; <strong>Bupropion</strong>, a norepinephrine and dopamine reuptake inhibitor, is a preferred option as it is a first-line antidepressant with a favorable side effect profile for this patient.&nbsp; It has <strong>mild stimulant effects</strong> and therefore can increase wakefulness, energy, and concentration.&nbsp; Bupropion is an approved treatment for <strong>smoking cessation</strong> and can also help with <strong>weight loss</strong>.&nbsp; It <strong>does not cause sexual side effects</strong>.&nbsp; Bupropion is contraindicated in patients with a history of seizures and those with eating disorders.</p><p><strong>(Choice A)</strong>&nbsp; Amitriptyline, a tricyclic antidepressant, is sedating and is not considered a first-line antidepressant due to its side effect profile (eg, cardiotoxicity, danger in overdose).</p><p><strong>(Choices B and D)</strong>&nbsp; Atomoxetine, a norepinephrine reuptake inhibitor, and methylphenidate, a stimulant, are used to treat attention-deficit hyperactivity disorder.&nbsp; This patient&#39;s impaired attention and concentration are symptoms of his depression.</p><p><strong>(Choice E)</strong>&nbsp; Mirtazapine, an antidepressant with serotonergic and noradrenergic activity, can be sedating and increase appetite.</p><p><strong>(Choice F)</strong>&nbsp; Modafinil is a wakefulness-promoting agent approved to treat narcolepsy.&nbsp; It has been used as an adjunct to improve motivation and energy in some patients with psychiatric illness.&nbsp; It is not an antidepressant and therefore not appropriate in this patient.</p><p><strong>(Choice G)</strong>&nbsp; Phenelzine, a monoamine oxidase inhibitor (MAOI), can cause weight gain and is not a first-line medication due to its dietary restrictions and potential for severe side effects (eg, hypertensive crisis, serotonin syndrome).&nbsp; Although MAOIs have been used to treat atypical depression (hyperphagia, hypersomnia, leaden paralysis, and rejection sensitivity), they are reserved for treatment-resistant cases.</p><p><strong>Educational objective:</strong><br>Bupropion is an antidepressant with mild stimulant properties that can be particularly helpful for depressed patients with low energy, impaired concentration, hypersomnia, and weight gain.&nbsp; It can also be used to aid smoking cessation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "3",
            "userAnswer": "7",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amitriptyline",
                    "choiceNumber": 1,
                    "correctTaken": 640,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Atomoxetine",
                    "choiceNumber": 2,
                    "correctTaken": 1217,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bupropion",
                    "choiceNumber": 3,
                    "correctTaken": 13762,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methylphenidate",
                    "choiceNumber": 4,
                    "correctTaken": 146,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mirtazapine",
                    "choiceNumber": 5,
                    "correctTaken": 754,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Modafinil",
                    "choiceNumber": 6,
                    "correctTaken": 114,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phenelzine",
                    "choiceNumber": 7,
                    "correctTaken": 394,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26940167",
                    "mediaDataId": 0,
                    "title": "Bupropion hydrochloride.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26940167",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18547129",
                    "mediaDataId": 0,
                    "title": "Spotlight on bupropion in major depressive disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18547129",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "17577801",
                    "mediaDataId": 0,
                    "title": "Bupropion and cognitive-behavioral treatment for depression in smoking cessation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/17577801",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 150,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 17027,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 3843,
            "questionIndex": 3843,
            "questionText": "<p>A 44-year-old man comes to the office due to depression, loss of interest, impaired concentration, fatigue, and poor sleep.&nbsp; The patient is not suicidal and has no psychotic symptoms.&nbsp; He has no psychiatric history.&nbsp; Physical examination and laboratory evaluation are unremarkable.&nbsp; Major depressive disorder is diagnosed, and he is treated with 50 mg of sertraline.&nbsp; After a month of antidepressant treatment, the patient reports improvement in his energy level and sleep, although he continues to struggle with some sadness and low motivation.&nbsp; The dose of sertraline is increased to 100 mg.&nbsp; At his 2-month follow-up, the patient has no depressive symptoms and says, &#x22;I feel like I&#39;m totally back to normal.&nbsp; Work is going well and I&#39;m really enjoying life again.&#x22;&nbsp; He has no adverse effects from the sertraline.&nbsp; The patient asks when he can stop taking the medication.&nbsp; Which of the following is the most appropriate response?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has achieved remission after acute-phase treatment with sertraline.&nbsp; To decrease the risk of depressive relapse, multiple evidence-based treatment guidelines recommend <strong>continuing antidepressant</strong> treatment for an <strong>additional 6 months</strong> in patients with remitted <strong>single-episode, unipolar major depression</strong> (referred to as <strong>continuation-phase treatment</strong>).&nbsp; The dose should be maintained at the level at which remission was achieved and should not be reduced (ie, the dose that gets the patient well keeps the patient well) <strong>(Choice A)</strong>.&nbsp; If complete remission is maintained at the end of the continuation phase, the antidepressant can then be tapered gradually and discontinued.</p><p>Maintenance-phase treatment is defined as continuing antidepressant medication past the initial continuation-phase treatment.&nbsp; Maintenance for 1-3 years is appropriate for patients with a high risk of recurrence (eg, &#8805;2 episodes, persistent residual depressive symptoms) <strong>(Choice B)</strong>.&nbsp; Patients with a history of highly recurrent major depressive disorder (&#8805;3 lifetime depressive episodes), chronic episodes (&#8805;2 years), strong family history, or severe episodes (eg, suicide attempt) should continue maintenance treatment indefinitely <strong>(Choice E)</strong>.</p><p><strong>(Choices D and F)</strong>&nbsp; Tapering and discontinuing sertraline now or in 6 weeks would increase the patient&#39;s risk for relapse.&nbsp; Sertraline should be maintained for an additional 6 months to achieve sustained remission.</p><p><strong>Educational objective:</strong><br>Patients with a single episode of major depressive disorder should continue antidepressants for an additional 6 months following acute response to reduce the risk of relapse.&nbsp; Patients with recurrent, chronic, or severe episodes should be considered for maintenance treatment (1-3 years or indefinitely).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Continue sertraline at a reduced dose for an additional 3 months",
                    "choiceNumber": 1,
                    "correctTaken": 1036,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue sertraline for 1-3 years",
                    "choiceNumber": 2,
                    "correctTaken": 1336,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue sertraline for an additional 6 months",
                    "choiceNumber": 3,
                    "correctTaken": 9472,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue sertraline for an additional 6 weeks",
                    "choiceNumber": 4,
                    "correctTaken": 657,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue sertraline indefinitely",
                    "choiceNumber": 5,
                    "correctTaken": 2110,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gradually taper off sertraline over several weeks",
                    "choiceNumber": 6,
                    "correctTaken": 2381,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "567,709,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25502491",
                    "mediaDataId": 0,
                    "title": "Duration of initial antidepressant treatment and subsequent relapse of major depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25502491",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23879318",
                    "mediaDataId": 0,
                    "title": "World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23879318",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 49,
            "othersAvgTimeSpent": 46,
            "notes": null,
            "peopleTaken": 16992,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 122,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 14452,
            "questionIndex": 15861,
            "questionText": "<p>A 5-year-old boy is brought to the office due to behavioral difficulties at school.&nbsp; His grandmother says, &#x22;This past year has not been easy for him, but he&#39;s been hitting other kids and breaking their toys.&#x22;&nbsp; The patient was adopted by his grandmother a year ago after his parents died in a motor vehicle collision.&nbsp; He attends the same school but no longer wants to play with his friends or join group activities.&nbsp; The patient wakes up a few times a week, crying about monsters and asking to sleep in his grandmother&#39;s room.&nbsp; He can ride a bike and draw complex shapes.&nbsp; Vital signs are within normal limits, and he is tracking adequately on growth curves.&nbsp; Physical examination is unremarkable.&nbsp; The patient is restless and rams a toy truck into a stuffed animal repeatedly while his grandmother speaks.&nbsp; He makes poor eye contact and answers most questions by saying &#x22;I don&#39;t know&#x22; despite his grandmother&#39;s encouragement.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This child&#39;s recurrent nightmares, violent themes in play, emotional reactivity with aggressive play (eg, hitting, breaking), and social withdrawal after a traumatic loss are suggestive of <strong>posttraumatic stress disorder (PTSD)</strong>.&nbsp; Exposure to trauma can occur through direct involvement in or witnessing of a traumatic event or by learning about violent trauma to a loved one.&nbsp; Young children with PTSD, whose memories may not be fully consolidated, often have <strong>nightmares</strong> that are not specific to the traumatic event (eg, monsters, being chased), as well as repetitive <strong>traumatic themes in play</strong>.&nbsp; They often struggle with <strong>emotional regulation</strong> and may appear easily upset or angered with little provocation.&nbsp; They may struggle with feelings of guilt, shame, or sadness.</p><p>Other manifestations include dissociation (which may be mistaken for not paying attention); avoidance of places, people, or discussions related to traumatic incidences; difficulty concentrating; decreased interest in play; and social withdrawal, as seen in this patient.</p><p><strong>(Choice A)</strong>&nbsp; Social withdrawal and repetitive acts of aggression toward peers are not typical behaviors for a 5-year-old and warrant further evaluation.</p><p><strong>(Choice B)</strong>&nbsp; Difficulty with emotional regulation and resultant impulsivity are often seen in childhood PTSD and may be mistaken for attention deficit hyperactivity disorder (ADHD).&nbsp; However, this patient lacks evidence of the pervasive inattention and hyperactivity required for the diagnosis of ADHD, and this diagnosis alone would not explain his nightmares, social withdrawal, and aggressive themes in play.</p><p><strong>(Choice C)</strong>&nbsp; This patient lacks the restricted interests and stereotypical behaviors typically seen in autism spectrum disorder.&nbsp; His poor eye contact and reluctance to engage with the physician are more likely due to avoidance of discussing distressing topics rather than the deficits in social communication characteristic of this disorder.</p><p><strong>(Choice D)</strong>&nbsp; Oppositional defiant disorder presents with an irritable mood accompanied by vindictiveness and defiance of rules, which is deliberate in nature rather than a result of emotional distress.&nbsp; It would not explain repeated nightmares and traumatic themes in play.</p><p><strong>(Choice F)</strong>&nbsp; Reactive attachment disorder is an extreme outcome of early childhood abuse, which results in a lack of emotional responsiveness and the absence of comfort-seeking from caregivers.</p><p><strong>Educational objective:</strong><br>Posttraumatic stress disorder in children may present with distressing dreams with vague content and reenactment of traumatic themes in play, rather than clearly formulated memories.&nbsp; This is often accompanied by emotional dysregulation and behavioral difficulties.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 11037,
            "topic": "Child and adolescent mental health",
            "titleId": 11037,
            "title": "Child and adolescent mental health",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Age-appropriate behavior",
                    "choiceNumber": 1,
                    "correctTaken": 1594,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Attention deficit hyperactivity disorder",
                    "choiceNumber": 2,
                    "correctTaken": 258,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autism spectrum disorder",
                    "choiceNumber": 3,
                    "correctTaken": 885,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oppositional defiant disorder",
                    "choiceNumber": 4,
                    "correctTaken": 724,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Posttraumatic stress disorder",
                    "choiceNumber": 5,
                    "correctTaken": 9967,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reactive attachment disorder",
                    "choiceNumber": 6,
                    "correctTaken": 2829,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "405,620,true,-1,1*795,1065,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28619857",
                    "mediaDataId": 0,
                    "title": "Pediatric&#160;PTSD&#160;in the DSM-5 and the forensic interview of traumatized youth.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28619857",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23674943",
                    "mediaDataId": 0,
                    "title": "Sleep disturbance in&#160;pediatric&#160;PTSD: current findings and future directions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23674943",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 125,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16257,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 584,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 13663,
            "questionIndex": 15053,
            "questionText": "<p>A 38-year-old woman with a history of hypertension, type 2 diabetes mellitus, and obesity comes to the office for a routine follow-up visit.&nbsp; Three months ago, the patient was diagnosed with a major depressive episode, characterized by a month of persistently depressed mood, isolative behaviors, staying in bed all day, low energy, poor concentration, and low libido.&nbsp; She was started on escitalopram, and a low dose of bupropion was added 6 weeks later to help with energy and concentration.&nbsp; She no longer feels depressed but is distressed that her libido remains low and her sexual arousal has decreased further.&nbsp; The patient does not use alcohol or recreational drugs.&nbsp; Other medications include metformin and enalapril, which she takes regularly.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 130/82 mm Hg, and pulse is 68/min.&nbsp; Examination shows no new abnormalities.&nbsp; Which of the following is the most likely cause of the patient&#39;s current sexual dysfunction?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41283\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>SSRI- &amp; SNRI-associated sexual dysfunction</strong></p></td></tr><tr><td><p align=\"center\"><strong>Features</strong></p></td><td><ul><li>Decreased libido</li><li>Anorgasmia</li><li>Delayed ejaculation</li><li>Common cause of nonadherence</li></ul></td></tr><tr><td><p align=\"center\"><strong>Assessment &amp; management</strong></p></td><td><ul><li>Rule out sexual dysfunction due to depression, medical conditions, primary sexual disorder, stress/relationship issues, substance abuse</li><li>Switch to non-SSRI or non-SNRI antidepressant: <strong>Bupropion or mirtazapine</strong></li><li>Adjunctive therapy with sildenafil or bupropion</li><li>Dose reduction for patients on high-dose SSRI (monitor for loss of efficacy)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRI</strong> = serotonin-norepinephrine reuptake inhibitor; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>The patient is most likely experiencing <strong>SSRI-induced sexual dysfunction</strong> secondary to treatment with escitalopram.&nbsp; Both selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) can cause sexual side effects.&nbsp; In women, these effects may include <strong>decreased sexual interest and arousal</strong> if mild or moderate, or anorgasmia if severe.&nbsp; In men, decreased libido, and in more severe cases <strong>erectile dysfunction</strong> and inability to ejaculate, may occur.</p><p>Psychological factors, substance use, and medical conditions such as vascular, hormonal, and neurological disorders may also cause sexual dysfunction.&nbsp; However, despite the presence of baseline obesity, diabetes, and hypertension in this patient, these conditions are stable and less likely to be responsible for the recent onset of her worsening sexual dysfunction <strong>(Choices C, F, and G)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Bupropion does not cause sexual dysfunction and is often tried as adjunctive therapy to manage SSRI-related sexual dysfunction.</p><p><strong>(Choice B)</strong>&nbsp; Depression-related sexual dysfunction would be expected to improve along with the patient&#39;s other depressive symptoms and therefore would not explain her worsening symptoms.</p><p><strong>(Choice E)</strong>&nbsp; Female sexual interest/arousal disorder is characterized by significant impairment in sexual arousal and interest lasting 6 months or longer; it is unrelated to substances, medications, or other medical etiologies.</p><p><strong>Educational objective:</strong><br>Serotonergic antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) can cause sexual dysfunction in both women and men.&nbsp; Psychiatric and other medical conditions can also cause sexual dysfunction.&nbsp; However, the temporal association of the symptoms (or their worsening) to SSRI/SNRI antidepressant use often indicates a medication-related cause.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 20929,
            "topic": "Selective serotonin reuptake inhibitors",
            "titleId": 20929,
            "title": "Selective serotonin reuptake inhibitors",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bupropion",
                    "choiceNumber": 1,
                    "correctTaken": 150,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Depression",
                    "choiceNumber": 2,
                    "correctTaken": 119,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diabetes mellitus",
                    "choiceNumber": 3,
                    "correctTaken": 47,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Escitalopram",
                    "choiceNumber": 4,
                    "correctTaken": 4370,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Female sexual interest/arousal disorder",
                    "choiceNumber": 5,
                    "correctTaken": 259,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypertension",
                    "choiceNumber": 6,
                    "correctTaken": 7,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obesity",
                    "choiceNumber": 7,
                    "correctTaken": 72,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27594188",
                    "mediaDataId": 0,
                    "title": "Antidepressant-induced sexual dysfunction.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27594188",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20664775",
                    "mediaDataId": 0,
                    "title": "Neurologic factors in female sexual function and dysfunction.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20664775",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 132,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 5024,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 87,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}